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Abstract
Economic losses that are caused by Mycobacterium avium paratuberculosis (MAP) infections
represent a major obstacle for farmers and also for the dairy industry. In order to control the
population of MAP, alternative control agents must be investigated. One of the studies described
in this thesis focused on using a bacteriophage therapy based approach to assess its efficacy on
simulated industrial environments and food models. Another study described in this thesis
investigated the antimicrobial effects of parsley and garlic on a range of mycobacteria species.
Both studies used conventional microbiological methods such as plaque assays, AlamarBlue
assay (MABA) and growth curves, and used fast growing M. smegmatis as a study model. The
results of the bacteriophage study indicated that mycobacteriophages have a potential application
as antimicrobial agents and could be used against pathogens such as MAP, when applied to any
industrial environments and also food models of rocket, milk and water. The results of the plant
extract experiments suggested that garlic could be selected for use as a potentially effective antimycobacterial agent in foods. These studies concluded that both bacteriophages and plant
extracts could be used as natural preservative agents and could provide an alternative to synthetic
antimicrobial agents.

CHAPTER 1: Literature Review

1.1 Introduction
There are a number of pathogens that have a negative impact on agriculture, including the dairy
industry. However, Mycobacterium avium paratuberculosis (MAP), which causes Johne’s
Disease (JD), has become one of the most significant, as it has caused great financial losses
through culling and trade restrictions (Harris and Barletta, 2001).
The increasing occurrence of antibiotic resistance together with a shortfall of novel classes of
antibiotics has created an urgency for the discovery of alternative antim.icrobial agents. There are
many concerns regarding food safety, such as residual effects of antibiotics in meats or animal
produce, that have triggered interest in finding viable alternatives for disease control.
Bacteriophages, probiotics, bacteriocins, herbs, avian egg antibodies and cytokines are only a
few modalities of treatment that are available nowadays and should be researched further
(Abhilash et al., 2009).

1.2 Paratuberculosis
As mentioned, Johne’s disease (JD) or paratuberculosis, is caused by exposure to MAP, which
leads to an intestinal granulomatous infection (Thorel et al., 1990).
JD is found worldwide among domestic ruminants such as cattle, sheep, goats, camelids and
buffaloes as well as wild ruminants. MAP has also been detected in other mammals including
horses, pigs, rabbits, stoats and weasels. In general, the disease spreads by ingestion of MAP

from the contaminated environment. The infection in calves occurs by ingestion of milk from
infected cows (Greig et al., 1999).
The disease is characterised by slowly progressive wasting and diarrhoea and protein-losing
enteropathy, followed by animal death (Collins, 2003).

The infection can be confirmed when early lesions start to appear in the walls of the small
intestine and in the draining mesenteric lymph nodes. As the disease develops, more bulky
lesions occur in the lower gastrointestinal tract including the ileum, jejunum, terminal small
intestine, caecum and colon. These lesions are responsible for protein malabsorption, which
results in muscle wasting. .ID can occur in animals at any age but is most frequently noted in the
3 to 5 year old age group and the clinical signs generally first occur in early adulthood (OlE
Terrestrial Manual, 2014).

1.2.1 Diagnosis
The identification of paratuberculosis can be broken down into two parts: the diagnosis of
clinical disease and the detection of subclinical infection. Diagnosis of JD is made on clinical
grounds confirmed by the presence of MAP in the faeces by microscopy, culture, or by the use of
DNA probes and the polymerase chain reaction. Diagnosis is made at necropsy by the finding of
the lesions in the intestines, with the presentation of typical acid-fast organisms in impression
smears of the lesions and by isolation of MAP in culture. The detection of subclinical infection
depends on the detection of specific antibodies by serology, or culture of MAP from faeces or
tissues collected at necropsy, or the presentation of cell-mediated responses. Cultures of MAP

may be collected from faeces or tissues, after treatment to eliminate contaminants, by inoculation
into artificial media with and without the mycobactin that is essential for the growth of MAP.
The

serological

tests commonly

used

for JD

in

cattle

are

absorbed

enzyme-linked

immunosorbent assay (ELISA), complement fixation (CF) and agar gel immunodiffusion
(AGID) (OlE Terrestrial Manual, 2014).
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factors severely limits its application; - = not appropriate for this purpose; * = post-mortem use only, ** - appropriate for the use
in sheep and goats. Although not all of the tests bsted as category ■*■■*■* or
have undergone fo^at validation, their routine
nature and the fact that they have been used widely without dutMous results, makes them acceptable.
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Table 1: Test methods available for diagnosis of paratuberculosis and their purpose (OIE
Terrestrial Manual, 2014).
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1.2.2 Distribution of paratuberculosis in cattle herds in Ireland
The economic losses that are caused by MAP infection in affected herds represent a major
obstacle for farmers and also for the dairy industry. The consequences of paratuberculosis
include reduction of milk production, alteration of milk composition, and an increase in somatic
cell count and in the occurrence of mastitis. In addition, animals can be more susceptible to many
infections or diseases and reproduction can be negatively altered (Vidic et ak, 1994). Potential
concerns relating to the safety of dairy products originating from the milk of infected animals
include a potential link between MAP and Crohn’s disease (Ghadiali et ak, 2004). JD could
become the most critical infectious disease affecting the Irish and international dairy industries.
JD has been a scheduled and notifiable disease in the Republic of Ireland since 1955. The disease
was rarely reported before the 1990’s and was generally reported in imported animals. Since the
introduction of the Single European Market in 1992 the number of incidences of paratuberculosis
in Ireland has increased. Due to the free movement of goods and services within the EU, cattle
could be imported from Europe with less requirements for testing and no certification prior to
importation, which would previously have included 6-months quarantine (Mee and Richardson,
2008).
The demography of MAP infections is poorly characterised and documented in Ireland. The first
bovine MAP positive submission was from a faecal sample originating from a pedigree
Limousin cow. The number of positive MAP cultures from bovine samples varied between 10
and 40%, however the data show an increase sum of submissions, particularly from 2002 when
the Department of Agriculture, Fisheries and Food took a proactive approach to JD (Mee and
Richardson, 2008).
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1.2.3 Characterisation and growth requirement of MAP
Mycobacteria are sturdy microorganisms that are highly resistant to many disinfectants, acids
and alcohols and they are harder to control than viruses, fungi or other bacteria (Rowland and
Niederweis, 2012).
Mycobacteriaeceae are bacteria that are often referred to as acid-fast bacilli. This family include
a number of significant human and animal pathogens. The pathogenic members of the
Mycobacteriaeceae family cause some of the most important human infections such as
tuberculosis or leprosy (Chadwick 1982).
MAP is an aerobic, catalase-positive and rod-shaped bacterium that measures approximately 0.5
pm wide and is I to 2 pm long. Iron is necessary for cell dlVlS® ion; it grows optimally at 37C,
at a pH above 5.5 and at salt concentration of less than 5% (Collins and Manning, 2012).
All mycobacterium species share a common characteristic that differentiate them from other
bacteria; that is they contain mycolic acids and other lipophilic niolecules in their cell wall (Li
and Bannantine, 2005). These features make all mycobacteria an “xtremely robust and resistant
genus (Griffiths, 2002).
MAP has one of the slowest replication rates among pathogenic mycobacteria. MAP colonies
usually start to appear after 3 months of incubation of contaminated samples from infected
animals at optimal conditions (Collins 2003).
Intracellular growth is another key characteristic of MAP infecdons. A host cell provides a
source of nutrients, protection from immune responses and from antibiotics (Bentham and
Whiley 2014).
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The MAP genome was first sequenced in 2005 using MAP strain KIO. The results of this process
revealed that MAP contains circular 4.83 Mbp chromosomes with 4350 predicted open reading
frames and contains a high GC content of 69% (Li and Bannantine, 2005).
A recent study defines the MAP genome as plastic and proves that genetic heterogeneity and
phenotypic differences exist between different MAP strains. MAP strains can be divided into two
main genotypes: sheep or ovine isolates (also called “S-type” or “type-1 and 111”) and cattle or
bovine isolates (also called “C-type” or “type 11”). Genomic polymorphisms between Type S and
Type C strains are great and are refected in the marked differences observed in phenotype
affecting cell growth, means of infection, pathogenesis and epidemiological traits. Conventional
typing systems fail to detect genetic diversity easily. Genome sequencing has revealed genetic
polymorphisms and in the near future SNP-based technologies will help to discriminate strain
differentiation. Limited data is currently available on the characteristics of particular
genotypically different MAP isolates of both Type S and Type C. Future studies are needed in
order to improve the identification of their genes (Stevenson, 2015).
One of the unique features of the Mycobacteriaceae genus is its cell wall structure, rich in
complex lipids. All mycobacteria produce ‘mycolic acids’ that coat the cell surface in a layer of
bacterial wax. This tough and waxy cell wall slows down or prevents the entry of antimicrobial
agents and is responsible for the persistence of the organisms, both in the environment and inside
the host (Bentham and Whiley 2014).
The lipids found in the cell wall account for 60% of total cell wall weight and may play an
important role in pathogenesis, including the bacteria’s ability to avoid the host’s immune
system.

Furthermore, mycobacteria are highly hydrophobic and resistant to many chemicals.
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Cell wall composition also affects cell permeability, as well as restricting the transport of solutes
into the cell, which could be responsible for its slow growth rate. Other elements that are found
in the cell wall include carbohydrates, soluble proteins and macromolecules such as
peptidoglycan, arabinogalactan and mycolic acids (Ratledge, 1982),
The existence of these characteristic lipids makes mycobacteria very difficult to grow in the
laboratory setting. The cells tend to clump together in the liquid media, causing them to settle at
the bottom of test tubes. Optical density is also very difficult to measure. MAP can be isolated
from environmental or faecal samples and it can take up to 6 months for cultures to grow. Strains
adapt to artificial media very slowly. However, when optimal conditions apply, cultures can
grow more rapidly and generally can be obtained in just over one month (Juan et al., 2006).
The mycobacterial cell wall is resistant to Gram stain, therefore this method of bacterial
characterisation is not applicable. The waxy nature of the cell wall means that the
decolourisation step using alcohol is not effective. Acid-fast staining can be used; this involves
the use of phenol dye, decolourisation and counter-staining with methyl blue. Cells will retain
the red phenyl dye (acid-fast positive) and appear red under the microscope, whereas other
bacteria will stain blue (acid-fast negative) (Saida et al., 1998).
Animal pasture can be easily contaminated with MAP from faeces and buried tissues from
infected animals. Roots, aerial plant parts and soil can contain bacterial DNA. MAP genetic
material has been found up to 80 cm deep in the soil (Kaevska et al., 2014).
Humans can be exposed to MAP in many ways, including pasteurised milk, baby milk formula,
surface water, soil or different crops in which cow manure is used as a fertilizer (Sechi and Dow,
2015).
14

MAP is classified as Risk Group 2 for human infection and should be handled with appropriate
measures when used in a laboratory setting.
Due to difficulties in propagating MAP in the laboratory and limited protocols available,
Mycobacterium smegmatis is often used as a surrogate organism (Hatfull, 2010). This nonpathogenic Mycobaeterium is a fast-growing organism that takes between 24 and 48 hours to
culture, and this makes it much easier to use in the laboratory setting. The survival and stability
of these species can be used to infer or predict the sustainability of antimycobacterial compounds
for MAP.

1.3 Antibiotic resistance
Antimicrobial resistance is becoming a serious problem on a global scale (Duckworth and Gulig,
2002). Bacteria undergo many radical changes in order to survive periods of starvation which
results in escalation of their resistance to a variety of environmental conditions (Kotler, 1992).
Antibiotics have been overprescribed in medicine and overused or misused as growth promotors
in farm animals.

Pathogenie organisms have the natural ability to develop resistance to

antibiotics and that is not only a threat to animal health but can also have far-reaching
consequences by accumulation of antibiotic residues in livestock products. This can have a
negative impact as it can lead to residual toxicity in farm animals and demonstrate dangerous
side effects. Ingestion of such foods create a hazard to human populations and in particular to
immunocompromised patients (Sulakvelidze et al., 2001).
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Infections that are caused by mycobacteria are difficult to treat as many strains are naturally
resistant to many antibiotics and require multiple drug therapies for prolonged periods of time
(Fox et al., 1999). The treatment for tuberculosis disease lasts for a minimum period of six
months, generally composed of two months’ treatment with four drugs, followed by four months
of two drugs (Rieder, 2002). If the therapy is not followed adequately the host may develop drug
resistant profiles. Some strains of multi-drug resistant tuberculosis are a major obstacle to the
control of the disease as they are generally incurable by the standard antibiotic regimes (Nachega
and Chaisson, 2003).
In agriculture, M. bovis and MAP are controlled by the culling of sick animals as treatment is
generally not provided (Caffrey, 1994).

1.4 Bacteriophages
Bacteriophages have proven that they are a valuable means to fight diseases that require a multi
dimensional approach. They also demonstrate the potential to control zoonotic pathogens as well
as showing their potential as beneficial alternatives to traditional antimicrobials such as
antibiotics. Prevention and treatment of infection by the use of bacteriophages in food safety
concerns may become very practicable in the near future.
Phages, as antibacterial agents, demonstrate a number of properties that make them compelling
alternatives to chemical antibiotics.

16

1.4.1 Ecology
Bacteriophages can be found wherever bacteria are present as they share a common ecological
system with their corresponding hosts. According to research, the most abundant bacteriophages
are found in the biosphere with a total number of 10 to 10 “ entities (Duran et al., 2002).
Phages can be found in the alimentary canal of humans and animals, as well as in foods, soil,
water, sewage and some ecosystems. They can be easily isolated from diverse sources such as
farmhouse sewage or waste waters (Sundar et al., 2009).

1.4.2 Features and Mechanism of Action
Bacteriophages can be described as tadpole-shape microorganisms that have their genetic
material in the form of DNA or RNA, encapsulated by a protein coat and, depending on their life
cycle, can be either lytic or temperate (Ackermann, 2012). Virulent phages undergo the lytic
replication cycle whereas temperate phages undergo the lysogenic replication cycle. The
replication cycle for these two phage types occurs generally in four major steps, however each
phage diverges on the specifics of each individual step. The first step involves binding of the
phage to the bacterial cell wall, due to interactions between its tail and specific receptors on the
host cell surface. In the second step, the viral genomic material enters through the cell wall using
the tail as a transport vessel (Brovko et al., 2012). As a result of this process, the virus controls
the host’s machinery for its own use, to replicate its genomic material and to provide necessary
components for its replication. Early transcribed genes are used to replicate the bacteriophage
genome, and later transcribed genes are used for morphogenesis and lysis. The replication cycle
ends when a progeny phage is released from the host cell (Madigan and Martinko, 2006).
17

Action

Visual step

Phages first attach to and
puncture the bacterial
membrane. Phage DNA
is injected into the host
cell.

The Host cell’s DNA
transcription is
suppressed, and phagespecific proteins are
synthesised instead.

New phages are
assembled, the host cell
membrane is disrupted,
and large numbers of
new phages are released
from the host bacterium,
which dies.
Table 1: Replication cycle of bacteriophage (Pictures taken from Medi-Mation Ltd/Science
Source).
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Most of the 6300 bacteriophages that have been studied under the electron microscope have a
hollow protein tail that plays a role in the transfer of phage genetic material into the host upon
infection (Ackermann, 2012).
Bacteriophages contain an enzyme (holin) that allows virion particles to enter as the enzyme
rapidly lyses the bacterial host cell wall. Particular lysins, such as those of phages of Gram
negative bacteria, are competent in affecting a bacterial host by a mechanism completely
independent of their enzymatic activity (Orito et al., 2004).
Temperate phages have the ability to incorporate their genome into host cell genetic material as a
prophage and can transfer virulent or other harmful genes from one bacterium to another by
mechanisms of transduction (Goodridge et al., 2003).
Bacteriophages are distinctive to particular species, self-limiting and ecologically friendly in
nature. They can survive in the gastrointestinal environments of humans and animals and can
reduce the threshold levels of pathogenic microorganisms such as Campylobacter, Salmonella,
Shigella, Staphylococcus or Escherichia. The phage host range does not have to be generally
restricted and some phages can have a wide host range (Shasha et al., 2004).
Bacteriophages are mostly composed of nucleic acids and proteins and therefore are naturally
non-toxic to the human body (Abendon and Thomas-Abendon, 2009). Some phage therapy
protocols emphasise the use of highly purified phage preparations, in order to minimise potential
risks of anaphylactic responses to bacterial components, such as endotoxins, which can be found
in phage lysates (Skurnik et al., 2007).
Bacteriophages have minimal impact on health protecting bacterial flora in humans and animals.
In comparison, many mainstream antibiotics, that possess a broad spectrum of activity, can lead
19

to superinfections such as antibiotic-associated Clostridium difficile colitis or Candida albicans
yeast infections (Carlton, 1999).
Production of a bacteriophage generally involves a combination of bacterial host growth and
lysate purification. The cost of host growth can differ depending upon particular species,
however the cost of purification appears to be low. The cost of phage production per unit can be
generally similar when compared to the costs of pharmaceutical manufacturing, however the
costs of isolation and characterisation can be relatively low (Skurnik et al., 2007).

1.4.3 Factors affecting replication of phages
There are several factors that can impact on the replication cycle of phages. These include pH,
organic matter, relative number of host bacteria and phage particles, or ionic concentration, to
name but just a few. Phage viability is generally at its optimal range between pH 5 and 9,
whereas pH values below 3 and above 11 cause complete inactivation of phage activity. Change
in temperature can affect synthesis of DNA in bacteriophages. This can be seen, for example, in
Phage29-infected Bacillus amyloliquefaciens, when temperature has been elevated. Naturally
occurring phage suspensions are stable at ranges between -20 to 5° C and ranges of -70 to 10° C
when protected with glycerol. Change in season can also influence the replication of phages,
specifically in the case of host-specific phages of Salmonella typhimurium and Bacteroides
firagilis as infection rates of these are increased during the summer season (Kinoshita et al., 1993;
Brenner et al., 1999).
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1.4.4 Phage therapy
A mycobacteriophage or mycophage is a type of phage that infects mycobacteria species and can
be isolated from both healthy and diseased individuals (Pedulla et ah, 2003).
In general, phages that are used in therapies are substantially different to classical chemicals or
mainstream medicines; however they are natural entities that play an important part in the
maintenance of equilibrium in bacterial populations in humans and animals. They can be
administered via intramuscular injections, aerosol spray or as an oral treatment (Comeau et al.,
2007).
Different phages can be combined together in the form of a cocktail, which can broaden their
properties, resulting in a collectively greater antibacterial spectrum of activity (Kutateladze and
Adamia, 2010).
In the veterinary field, phage therapy generally focuses on aquaculture and various food products
that have the potential to prevent food-borne and zoonotic bacterial pathogens (Soothill et al.,
2004).
The literature reveals that oral administration of phage to mice, guinea pigs and livestock is used
to demonstrate efficacy against a number of pathogenic microorganisms such as E. coli,
Pseudomonas, Staphylococcus and Salmonella species (Summers, 2001).
Phage therapy has many advantages over antibiotics and can be very effective in cases of
multidrug-resistant pathogenic microorganisms. In addition, they do not affect the natural
microflora of the gut and are comparatively safer and have minimal side effects, while being
cost-effective (Sulakvelidze et al., 2001).
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1.4.5 Biocontrol
Biocontrol is the introduction of particular organisms into ecosystems such as croplands, in order
to eliminate species that have become pests. Pathogenic bacteria are pests that infect our bodies
and phages represent a form of biocontrol. A small number of studies refer to phage therapy as
biocontrol of bacteria found in association with plants, fungi and their products. Bacteriophagemediated biocontrol has been successfully implemented in some plant pathogens. These include
control of Xanthomonas pruni, which is associated with bacterial spots on peach trees,
Xamthomonas infections of cabbage and peppers, treatment of Ralstornia solanacearum which
causes infection in the tobacco plant, and control of blotches in mushrooms caused by
Pseudomonas tolaasii (Lawrence and Abedon, 2003).
Bacteriophage-mediated biocontrol could potentially be used as the obvious alternative to
traditional chemical anti-microbials.
Lytic phages possess ideal properties to serve as agents of both antibacterial biocontrol and
bacterial identification. Bacteriophages might work in the near future as both bacteria detection
tools and biocontrol agents in clinics, on farms, and even in factories.
Farm animals generally live within relatively enclosed environments but are exposed to many
drugs and antibiotics. If phage therapy was to be introduced to farm animals it could not only
reduce the food pathogen load but also decrease the overall antibiotic usage.
Many researchers and companies focus on food safety and agricultural and industrial
applications of bacteriophages. A number of companies established products containing phages
that target specific bacteria and are approved by the EPA, USDA and FDA. ListShieldTM
(produced by Intralytix) and LISTEXTM PI00 (produced by MICREOS, formerly EBI) are
22

sterilizing agents that target Listeria monocytogenes in ready-to-eat foods and represent some of
the first examples of phage cocktails to obtain Generally Recognized As safe (GRAS) status
from the FDA (Abuladze et al., 2008).

1.4.6 Further Applications
Phage therapy can be simply described as control of pathogens with the use of bacteriophages in
a clinical setting or when administrated to animals. Bacteriophage processing, on the other hand,
is control with bacteriophages as a means of eliminating or altering food bacterial loads. This
method is generally applied in the production of minimally processed foods, usually in order to
avoid cooking, as this can lead to loss of flavour or texture (Lawrence and Abedon, 2003).
Control of pathogens with phages has been reported in the food processing environment. There
are a number of applications that have been successfully applied, such as extending animalproduct shelf life (Greer and Dilts, 2002), control of biofilm-forming bacteria in draining
systems (Himba et al., 1997) or even lysing lactic acid bacteria, thus contributing to the ripening
of Camembert and Cheddar cheese (Crow et al., 1995).

1.4.7 Mycobacteriophage
The phages that infect mycobacteria are known as mycobacteriophages and were first discovered
in 1946 from samples containing soil and leaf mould (Gardner and Weiser 1947).
In 1954, another mycobacteriophage was discovered which infected pathogenic bacilli of the M.
tuberculosis complex. So far, over two hundred different mycobacteriophages have been
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described, which infect a broad variety of mycobacterial hosts. These have been isolated from a
variety of environmental sources, such as soil or surface water (Froman et al., 1954) and
specimens of patients with tuberculosis or sarcoidosis (Mankiewicz, 1961). The majority of
mycobacteriophages are double-stranded DNA viruses with non-contractile tails that belong to
the Siphoviridae family of bacteriophages (Ackermann, 2001). Mycobacteriophages are
frequently utilised in molecular research laboratories, where they are invaluable tools in the
genetic manipulation of mycobacteria (McNerney, 1999).
In one study, six mycobacteriophages were isolated from a variety of environmental samples and
tested against M. smegmatis in reconstituted milk. It was found that individual phages typically
reduced host number by up to 7-logs and when tested as a phage cocktail they demonstrated an
even stronger bacteriocidal effect, evidenced by a 9-log reduction of host cells. These results
indicated that mycophages may have a potential application as anti-mycobacterial agents in milk
(Endersen et al., 2012).
Phage TM4 is one the most documented mycobacteriophages that infects both slow and fast
growing mycobacteria. In one study, the mureinolytic activity was assessed by cloning,
expressing and purifying the putative lysate. The results showed evidence of peptidoglycan
degrading activity caused by the lysin A gene from the mycobacteriophage TM4 (Henry et al.,
2010).

1.5 Bioluminescence
Bioluminescence is the production of light by luciferase-catalysed reactions. This reporter
technology has many applications and can be used both in vitro and in vivo. Bioluminescence
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imaging can be applied to many studies of infectious disease where luciferase-expressing cells
within animals can be observed in real-time (Hutchens and Luker, 2007).
Luminous organisms are extensively present in nature and include bacteria, dinoflagellates,
fungi, fish, insects, shrimp and squid. Bacteria, however, are the most abundant and widely
distributed of the light-emitting organisms and are found in many different ecosystems such as
marine, freshwater and terrestrial settings (Nealson and Hastings, 1979).
Luciferases belong to a large group of enzymes that catalyse the oxidation of luciferin, to yield
oxyluciferin with the production of light as a result. In general, three major luciferin-luciferase
systems are used for imaging. The first system is defined by the firefly luciferase (FFluc) that
originates from Photinus pyralis. This system uses D-luciferin as substrate and is dependent on
the presence of ATP and results in the production of yellow-green light of 557 nm. The second
system is represented by luciferases known as coelenterazine from the organisms Renilla
reniformis and Gaussia princeps. The signal produced by the G. princeps luciferase (Glue) emits
light in the blue spectrum of 480 nm and is strongly susceptible to tissue absorption and
scattering and also resistant to heat and extreme pH. The third system includes bacterial
luciferases found

in the terrestrial

bacterium

Photorhahdus luminescens and

marine

microorganisms from the genera Vibrio and Photobacterium (Tannous et al., 2005). These
luciferases use FMNH2 and a long-chain aldehyde as substrates. Bacterial luciferases are
encoded by the genes luxkB that form an operon (/wxCDABE) together with three additional
genes (/iccCDE) whose products synthesise the long chain aldehyde (Andreu et al., 2010).
Bioluminescence has been used in mycobacteria research for over two decades.

Originally,

FFluc was use to quantify ATP as an indirect method for assessing cell viability and cell
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numbers. More recently, IwcAB and FFluc have been used in M smegmatis, M. tuberculosis, M.
bovis, M avium, M intracellulare and M. aurum (Gordon et al., 1998).

Use of luciferase

reporter bacteriophages allowed for further improvements in testing of the drug susceptibility of
bacteria of clinical importance and research of tuberculosis diagnostics (Jacobs, 1993). In
addition, bioluminescence has been implemented in antibiotic testing and immunity assessment
in cell cultures and ex vivo in infected mice (Hickey et al., 1996). In a 2010 study, the I VIS® (In
Vivo Imaging System) was used to demonstrate the effective elimination of a lux labelled S.
aureus from the nares of BALB/c mice (Fenton et al., 2010).
The expression of the lux genes in different bacteria can provide a simple and sensitive method
for monitoring the growth and circulation of the bacteria in the ecosystems. This can be also
used in antibiotic susceptibility testing or testing of toxic materials as the agents that inhibit or
kill bacteria almost always impair metabolisms, thus reducing light emission. For example, milk
that contains antibiotics, bacteriophages or other toxic compounds that could inhibit the
Lactobacillus starter culture in the fermentation process, can be monitored by the reduction of
light emission by using Lactobacillus transformed with the lux gene (Meighen, 1991).
The sensitivity of identifying internal light sources depends on a number of factors such as the
level of luciferase expression, the distance that the photons must pass through tissue and the
sensitivity of the detection system (Wilson and Hastings, 1998). Photons are identified by
specialised charge couple device (CCD) cameras that convert photons into electrons after
striking silicon wafers. These cameras encode the intensity of incident photons into electrical
charge patterns to generate an image. For example, the assessment of bioluminescence (photons
s-lcm-2 steridian [sr]-l) from living animals can be performed using the I VIS® system that
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consists of a cooled CCD camera mounted on a light-tight specimen chamber. This system is
run by a computer for image processing and analysis (Sadikot and Blackwell, 2005).

1.6 Antimicrobial activity of medicinal plants
Medicinal plants have been used in the treatment of many diseases for centuries and still offer
hope for developing new alternatives to modern medicines. They can be used broadly as pure
compounds or as a crude material (Heinrich, 2001).
The plant kingdom provides an important source of new medicines that can be used as a
treatment of mycobacteria-caused diseases due to its extensive chemical diversity. A great
number of modern drugs have been derived from medicinal plants and these include quinine,
codeine and morphine (Chin et al., 2006).
Many plants have the ability to synthesize aromatic substances and secondary metabolites that
are so important in the processes of new drug discovery. Phytochemicals can be extracted from
plant material using different solvents including alcohols, chloroform, hexane, ether and most
popularly water. Alcohol and water solvents are used to extract poplar compounds while hexane
and ether extract the non-polar components (Cowan, 1999).

1.6.1 Allium sativum L
Allium sativum L, commonly known as garlic, has played an important role in diet and medicine
for many centuries. It possesses many therapeutic activities that benefit the cardiovascular
system and it has demonstrated antibiotic, anticancer, anti-inflammatory and hypoglycemic
effects in humans and animals (Jonkers et al., 1999). In addition, it has antibacterial activity
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against many common pathogenic bacteria. This broad spectrum of activity has been attributed to
the more than one hundred phytotherapeutic sulfur compounds present in varying concentrations
in garlic.

/

Figure 1: Bulbs and cloves of Allium sativum L

A clove of garlic contains the inactive ingredient alliin. Once the clove cells are broken or
crushed, then the enzyme allinase is released. Allinase converts alliin into allicin, which is
biologically and chemically active. Therefore, the activity of the product is based on allicin
content. Other important molecules derived from garlic include 2-propenesulferic acid and
tioacrolein that in turn result in the formation of molecules such as diallyl, trisulfide and dithiin
(Guo et al., 2012). The antibacterial activity of garlic extracts is attributed to the presence of
these compounds, which effectively cause disruption of cell components and have the ability to
block enzyme pathways that have been implicated in bacterial inhibition (Rabinkov et al., 1998).
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Many different Gram-positive and Gram-negative bacteria strains can be inhibited by exposure
to garlic (Bakri and Douglas, 2005).

Figure 2: Chemical formula of Allicin

Garlic preparations have demonstrated a wide spectrum of antibacterial activity against species
of Escherichia, Salmonella, Staphylococcus, Streptococcus, Klebsiella, Proteus, Bacillus, and
Clostridium and even M. tuberculosis has shown some degree of sensitivity (Uchida et af, 1975).
Garlic formulations have successfully inhibited the growth of Helicobacter pylori which can be
involved in the formation of gastric ulcers (Cellini et al., 1996).
Garlic has also demonstrated strong antifungal activities against the synthesis of mycotoxin
produced by Aspergillus parasiticus (Koch and Lawson, 1996). Pure allicin has proven excellent
anticandidial activity with a minimum inhibitory concentration of 7 pg/mL (Hughes and Lawson,
1991).
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Crushed garlic also has antiparasitic properties that are well known in many human cultures. The
human intestinal protozoan infection caused by Entamoeba histolytica can be treated with only
30 pg/mL of allicin (Mirelman et al., 1987).
Fresh garlic has been shown to have in vitro and in vivo antiviral activity. The list of viruses that
are sensitive to garlic extracts include the human Cytomegalovirus, Influenza B, Herpes simplex
virus type 1, Herpes simplex virus type 2, Parainfluenza virus type 3, Vaccinia virus, Vesicular
Stomatitis virus, and Human Rhinovirus type 2 (Tsai et al., 1985).
The antituberculosis activity of garlic in vivo was demonstrated in a study where guinea pigs
were administered an intraperitoneal dose of 0.5 mg/kg of garlic oil preparation (Jain, 1993).
Another study of garlic demonstrated the inhibition of Mycobacterium tuberculosis H37Rv and
Mycobacterium tuberculosis TRC-C1193, susceptible and resistant to isoniazid, respectively.
The minimum inhibitory concentration (MIC) was between 80 and 160 pg/ml for the susceptible
strain and between 100 and 200 pg/ml for the resistant strain (Ratnakar and Murthy, 1996).

1.6.2 Petroselinum crispum
Petroselinum crispum, commonly known as parsley, belongs to the Apiaceae family and
possesses many therapeutic activities that benefit the urinary system, due to its diuretic effect,
and also demonstrates many other beneficial properties such as emmenagogue, antispasmodic,
carminative, and expectorant effects. Parsley tea and expressed juices are used in herbal
medicine and are effective laxative, hypotensive, uterine tonic and antimicrobial agents
(Blumenthal, 1998).
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The two major phenolic compounds extracted from parsley flakes were identified as apiin and
malonyl-apiin (Devananad, 2008). Parsley contains several other biologically active components
which include ascorbic acid, carotenoids, flavonoids, coumarins, myristicin, apiole, various
terpenoic compounds, phenyl propanoids, phthalides, furano coumarins and tocopherol
(Yanardag et al., 2003). Parsley has demonstrated some antibacterial and antifungal activity
when tested in vitro. Furocoumarins extracted from four varieties of fresh and freeze-dried
parsley leaves inhibited Escherichia coli 0157:H7, Listeria monocytogenes, Erwinia carotovora,
and Listeria innocua (Manderfeld et al., 1997).

OH
OH

O

OH

O

OH OH
Figure 3: Chemical formula of apiin

Studies on the antioxidant and antibacterial activities of parsley leaves and stems have been
investigated using methanol and water as solvents. Methanol leaf extract exhibited greater
radical-scavenging activity toward both lipid and water-soluble radicals. This parsley
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formulation caused bacterial cell damage and strong growth inhibition of B. suhtilis and E. coli
(Peter et al., 2006).
Rats with diabetes treated with parsley demonstrated significantly lower levels of blood glucose,
alanine transaminase and alkaline phosphatase, indicating that it may have multifunctional
properties (Bolkent et al., 2004).

1.7 Summary
As previously mentioned, the economic losses that are caused by MAP infections in affected
herds represent a major obstacle for farmers and also for the dairy industry. In order to control
the population of MAP, alternative control agents must be investigated. Having reviewed the
relevant literatures, the following experimental chapters will focus on the use of a bacteriophage
therapy-based approach to assess efficacy on simulated dairy environments and food models, and
also investigate the antimicrobial effects of parsley and garlic on a range of mycobacteria
species. Both studies will use conventional microbiological methods such as plaque assays,
MABA assay, and growth curves. Fast growing M. smegmatis will be used as a surrogate study
model. The key deliverables of these experiments will be to assess if bacteriophages and plant
extracts can be used as natural preservative agents which can provide alternatives to synthetic
antimicrobial agents for use against mycobacterial pathogens such as MAP.
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CHAPTER 2: An investigation of the use of natural agents to control
mycobacteria

Abstract
Economic losses that are caused by MAP infection in affected herds represent a major obstacle
for farmers and also for the dairy industry. In order to control the population of MAP, alternative
control agents must be investigated. Using Mycobacterium smegmatis as a host, two
mycobacteriophages were isolated from environmental samples, bacteriophage AS S from
activated sludge and bacteriophage BWC VB from water sample. The host range study was
conducted on M. smegmatis me

155, M. kansasii, M. avium intracellulare, M. avium

hominissuis, M. tuberculosis H37Ra and MAP strain KIO. Results revealed that both phages
showed activity against M. smegmatis and M. tuberculosis strains. Electron micrographs revealed
virions to have the characteristic isometric head and long non-contractile tail of the Siphoviridae
family. Antimycobacterial activity was tested on individual phages (AS S and BWC VB), and on
a phage cocktail (combination of LEI, LE2, LE3, LE4, LE5, LE6, AS S and BWC VB purified
phages at 10^ PFU/mL). In the first study described in this thesis, bioluminescence was used to
assay antimycobacterial activity of bacteriophage in order to assess cell viability and cell
number. Single bacteriophage lysate reduced the culture growth by 87.8% at its highest
concentration, whereas phage cocktail caused a reduction of 98.4%. Surface decontamination
studies proved that matrix has an impact on phage activity, as results varied when tested on
different surfaces. Single phage formulation significantly reduced M. smegmatis contamination
on the wood surfaces by 78.33%, and phage cocktail formulation by 87.70%. When tested on
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glass, single phage formulation had weaker efficacy as it reduced bacterial growth by 56.13%,
whereas phage cocktail treatment reduced it by 93.96%. Phage formulation showed low efficacy
when applied on rubber as the single phage reduced the cell growth by only 13.70 % and phage
cocktail by 35.30%. When tested on metal, single phage reduced M smegmatis by 37.78% and
phage cocktail by 61.39 %. The application of individual bacteriophages in the food model
resulted in 18.25% reduction of viable cells and in the phage cocktail a 55.88 % reduction of M.
smegmatis when tested on rocket. When tested in milk, single phage formulation had a weak
inhibitory effect of 29.58%, whereas phage cocktail demonstrated stronger activity of 59.54 %.
When used to test phage activity in water, individual phage lysate had a limited antimicrobial
effect of 29.07%, whereas phage cocktail formulation resulted in 63.44% inhibition of cell
population. Another study investigated the antimicrobial effects of parsley and garlic on a range
of mycobacteria species. The first part of the study focused on assessing the efficacy of synthetic
compounds and plant extracts using an AlamarBlue assay (MAE3A). The eleven compounds
tested in the MABA assay did not show strong antimicrobial effects, therefore they do not have
the potential to become new drugs for the control of mycobacteria. This study, however, revealed
that garlic possessed inhibitory effects against different mycobacteria, depending upon whether
in solvent and dry or fresh states. Fresh garlic formulation showed the weakest activity against
mycobacteria among all garlic extracts tested. It demonstrated activity against M smegmatis, M.
kansasii M. iatacellulare and M. hominissuis at an MIC of 1000 pg/mL. Methanol extract (20%)
demonstrated stronger activity and resulted in inhibition of A/, smegmatis, M. kansasii M.
intacellulare and M. hominissuis at 125, 500, 1000 and 500 pg/mL accordingly. The most
effective extract tested was dried garlic water formulation as it resulted in bacterial inhibition of
M. smegmatis, M. kansasii M. intacellulare and M. hominissuis at 125, 250, 1000 and 250
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^g/mL accordingly. The second part of the study investigated the antimycobacterial effects of
garlic and parsley using growth curves of the fast growing M. smegmalis. This experiment
confirmed that fresh and dried garlic water extracts demonstrated a complete inhibiting effect
against the tested bacterial cultures. Finally, the antimycobacterial activity of garlic extract was
demonstrated in a food model of lettuce against M. smegmatis. From this it was shown that garlic
water extract caused a reduction of 34.69% of total bacterial cell count. These experiments
suggested that bacteriophage and plant extracts could be selected lor use as potentially effective
anti-mycobacterial agents when applied to any industrial environments and/or food models.

35

2.1 Introduction
Johne’s disease (JD) which is also known as paratuberculosis is a chronic infectious disease that
affects ruminants, including dairy and beef cattle. JD is caused by Mycobacterium avium subsp.
paratuberculosis (MAP) and is not uncommon in Ireland.
A random survey conducted in Ireland during 2005 estimated the prevalence of paratuberculosis
in the cattle population. The overall prevalence of infected herds, based on the presence of at
least one ELlSA-positive animal, was 21.4% (Good et al., 2009).
This mycobacterium, when present in cattle, causes chronic granulomatous degenerative enteritis
that in effect results in persistent diarrhoea, weight loss and eventually in animal death.
Unfortunately the disease is incurable and slowly progressive (Stehman, 1990). Economic losses
that are caused by MAP infection in affected herds represent a major obstacle for farmers and
also for the dairy industry. Consequences of paratuberculosis include reduction of milk
production, alteration of milk composition, and an increase in somatic cell count and in the
occurrence of mastitis. In addition, animals can be more susceptible to many infections or
diseases and reproduction can be negatively altered (Vidic et al., 1994). The infected animals
remain asymptomatic for two to ten years during which MAP spreads throughout in low and
nearly undetectable numbers (Collins and Manning, 2012). Animal pasture can be easily
contaminated with MAP in faeces and buried tissues from infected animals. Roots, aerial plant
parts and soil can contain bacterial DNA. MAP genetic material can be found up to 80 cm deep
in the soil (Kaevska et al., 2014). This emerging infectious disease has been present in Irish
cattle herds for decades, however, since the introduction of the Single European Market in 1992
it has become more widespread as the number of imported cattle from the EU dramatically
increased (Hoogendam et al., 2009). The symptoms that are characteristic to JD share many
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similarities to those of Crohn’s disease (CD) in humans, however the evidence that MAP is the
are

inconclusive

(Mihajlovic

et

al.,

2011).

Mycobacterium

causative

agent

avium

paratuberculosis {Mk?) has one of the slowest replication rates amongst

pathogenic mycobacteria. MAP colonies usually start to appear after three months of incubation
of contaminated samples from infected animals at optimal conditions (Collins, 2003).
Intracellular growth is another key characteristic of MAP infections. A host cell provides a
source of nutrients, protection from immune responses and from antibiotics (Whiley et al., 2012).
Mycobacterium smegmatis is a fast-growing and non-pathogenic organism that shares many
similar characteristics with the pathogenic MAP and therefore it was chosen as a study model to
demonstrate the antimycobacterial activity of bacteriophages.
Bacteriophages (phages) are typically species, if not strain-specific, viruses of bacteria. These
viruses infect the bacterial host, replicate their own genome, transcribe phage DNA to produce
proteins that are used to produce new virions, and lyse the cell to exit which results in cell death
(Lin et al., 2010). One of the experiments involved in this study used bioluminescent organisms
to demonstrate the bacteriophage activity in vitro. Bioluminescence is the production of light by
luciferase-catalysed reactions (Andreu et al., 2010). Optical imaging of bacterial growth/>?
v/7ra using engineered bioluminescent M. smegmatis pMV 361-lux was used to assess the
antimicrobial activity of the bacteriophages. The objective of this study was to isolate
mycobacteriophages, and characterise them using plaque morphology, transmission electron
microscopy (TEM) and host range studies. Characterized bacteriophages were tested individually
and as a phage cocktail and used as a potential treatment in the control of mycobacteria
populations in any industrial and food environments.
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Plants and other natural products play an important role in sourcing new therapeutic agents.
Many drugs available as therapeutics are derived from natural origins such as plants,
microorganisms or animals (Calixo, 2005). Screening plant extracts has led to the discovery of
many pharmacologically active compounds that are used as drugs to treat many human diseases
(Shu,

1998). A number of plant species have been shown to demonstrate strong

antimycobacterial effects in vitro and this has led to further research towards the isolation of
efficacious phytochemicals (Newton et al., 2002). The presence of antimicrobial resistance has
become a great risk to public health and can lead to a global impact on agriculture and industry
(Hampton, 2013). An increase in the number of cases of resistant and multi-drug resistant
mycobacterial stains suggests that alternative treatments should be developed (Silva et al., 2006).
Antibiotic susceptibility testing is important to determine the appropriate therapy so the
appropriate antibiotics can be used to control mycobacterial infections, fhere are a number of
antibiotics that show inhibitory effects on different strains of Mycobacteria and these include
rifampicin,

isoniazid,

pyrazinamide

and

ciprofloxacin.

Rifampicin

is

produced

from

Streptomyces mediterranei and has a broad antibacterial spectrum. It inhibits DNA-dependent
RNA polymerase activity by forming a stable complex with the enzyme, thus suppressing the
initiation of RNA synthesis (Gilman et al, 2011).

Ciprofloxacin works by inhibiting

deoxyribonucleic acid gyrase that is needed for replication of bacterial DNA (LeBel, 1988).
Pyrazinamide is a unique antituberculosis drug that inhibits multiple targets including energy
production and potentially pantothenate/coenzyme A, which is required for survival (Zhang et al,
2014). The antimicrobial activity of isoniazid is selective for mycobacteria likely due to its
ability to inhibit mycolic acid synthesis, which interferes with cell wall formation, thus
producing a bactericidal effect (Zhang et al, 2005).
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Allium sativum L, commonly known as garlic, has played an important role in diet and medicine
for many centuries. It possesses many therapeutic activities that benefit the cardiovascular
system and it has demonstrated antibiotic, anticancer, anti-inflammatory and hypoglycemic
effects in humans and animals (Jonkers et al., 1999). In addition, it has antibacterial activity
against many common pathogenic bacteria. This broad spectrum of activity has been attributed to
the more than one hundred phytotherapeutic sulfur compounds present in varying concentrations
in garlic. Allicin is the main compound which is biologically and chemically active. Other
important molecules derived from garlic include 2-propenesulferic acid and tioacroleinm, which
in turn result in the formation of molecules such as diallyl, trisulfide and dithiin (Guo et al.,
2012). The antibacterial activity of garlic extracts is attributed to the presence of these
compounds, which effectively cause disruption of cell components and have the ability to block
enzyme pathways that have been implicated in bacterial inhibition (Rabinkov et al., 1998). Many
different Gram-positive and Gram-negative bacteria strains can be inhibited by exposure to garlic
(Bakri and Douglas, 2005).
Petroselinum crispum, commonly known as parsley, also possesses many therapeutic activities
that benefit the urinary system due to its diuretic effect and it also demonstrates many other
beneficial properties such as emmenagogue, antispasmodic, carminative, and expectorant effects.
Parsley tea and expressed juices are used in herbal medicine and are effective laxative,
hypotensive, uterine tonic and antimicrobial agents (Blumenthal, 1998). Parsley contains several
biologically active components which include ascorbic acid, carotenoids, flavonoids, coumarins,
myristicin, apiole, various terpenoic compounds, phenyl propanoids, phthalides, furano
coumarins and tocopherol (Yanardag et al, 2003). Parsley demonstrated some antibacterial and
antifungal activity when tested in vitro. Furocoumarins extracted from four varieties of fresh and
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freeze-dried parsley leaves inhibited Escherichia coli 0157:H7, Listeria monocytogenes, Erwinia
carotovora, and Listeria innocua (Manderfeld et al, 1997).
Screening of plant secondary metabolites is an excellent method of finding new biological agents
that can be used in the control of mycobacterial populations. In this study, the antimycobacterial
activity of parsley and garlic were evaluated.
In summary, this research aim to look at methods of elimination and control of mycobacteria
using bacteriophages and plant extracts in the study model of M. smegmatis and are apply to
food settings and industry.
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2.2 Materials and Methods
2.2.1. Bacterial isolates

Bacterial strain

Relevant Information

Source

Mycobacterium smegmatis mc^
155

Stocked and stored at
-80“C and -20°C
Working culture stored at 4°C, in
BHI broth.

Bacterial Culture Collection of
Cork Institute of Technology

Mycobacterium smegmatis pMV
361-lux

Stocked and stored at
-80“C and -20°C
Working culture stored at 4°C, in
BHI broth.

Bacterial Culture Collection of
Cork Institute of Technology

Mycobacterium kansasii

Stocked and stored at
-SOX and -20^
Working culture stored at 4°C, in
BHI broth.

Bacterial Culture Collection of
Cork Institute of Technology

Mycobacterium awium
intracellulare

Stocked and stored at
-80“C and -20“C
Working culture stored at 4°C, in
BHI broth.

Bacterial Culture Collection of
Cork Institute of Technology

Mycobacterium avium
hominissuis

Stocked and stored at
-SO^C and -20“C
Working culture stored at 4°C, in
BHI broth.

Bacterial Culture Collection of
Cork Institute of Technology

Mycobacterium tuberculosis
H37Ra

Stocked and stored at
-SO^C and -20‘’C
Working culture stored at 4“C, in
BHI broth.

Bacterial Culture Collection of
Cork Institute of Technology

Mycobacterium avium
subspecies paratuberculosis
strain KIO

Stocked and stored at
-80°C and -20°C
Working culture stored at 4°C, in
Middlebrook 7H9 Broth Base with
BBLTM
Middlebrook
OADC
Enrichment.

Bacterial Culture Collection of
Cork Institute of Technology

Table 1: List of bacterial cultures including storing conditions and source used during this study.

41

2.2.2 Bacteriophage
Relevant Information

Bacteriophage name

BWCVB

ASS

LEI

LE2

LE4

LE3
LE5
LE6

Isolated from bathroom water
sample from a city centre cafe in
Dublin.
Stored at 4°C, in BHI broth.
Titred/propagated in M. smegmatis
mc^ 155.
Isolated from activated sludge.
Stored at 4°C, in BHI broth.
Titred/propagated in M. smegmatis
mc^ 155.
Isolated from chicken run.
Stored at 4“C, in BHI broth.
Titred/propagated in M. smegmatis
mc^ 155.
Isolated from stable bedding
Stored at 4°C, in BHI broth.
Titred/propagated in M. smegmatis
mc^ 155.
Isolated from compost.
Stored at 4“C, in BHI broth.
Titred/propagated in M. smegmatis
mc^ 155.
Isolated from soil.
Stored at 4°C, in BHI broth.
Titred/propagated in M. smegmatis
mc^ 155.

Source

Environmental sample

Environmental sample

Endersen et al., 2013

Endersen et al., 2013

Endersen et al., 2013

Endersen et al., 2013

Table 2: List of bacteriophages including storing conditions and source used during this study.

2.2.3 Plant Materials
2.4.1 Garlic bulbs (Dunnes Stores, Ireland)

2.4.2 Dried Garlic (Tesco, Ireland)

2.4.3 Dried Parsley (Tesco, Ireland)
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2.2.4 Chemical compounds tested

Name

Structure

Properties

MW=

254.28
21,89

g/mol

PH 58

Mass [mg]

C13H18O5

OH

MW=

-OH

268.31
9,32

g/mol

PH 114.2

CiAHjnOi;

HO

OH

,NOo
-OH

MW=

299.28
14,05

g/mol

PH 103.6

C13H17NO7

HO

OMe

MW=

314.33
23,67

g/mol

PH 138.7

C15H22O7

OMe

MeO.

,OMe

MW=

314.33
11,91

g/mol

PH 114.3

C15H22O7

O7N,

MW=
g/mol

PH 113.6

C13H17NO7

43

299.28
7,27

M=257.35 g/mol
C H NOS
15

AP 18

3141

M=207.29 g/mol

AP 21
/=Wo-c'
\J-^

AP 22

15

/

s

/=\

p-6[

CiiHisNOS

2235

M=243.32 g/mol
C H NOS

56,56

14

/=\

13

M=257.35 g/mol
AP 23

C15H15NOS
(\
/>--- ^
\ //

40,68

NH

M=207.29
AP 27

C11H13NOS

NH'^

62,92

^ ^

Table 3: Name, chemical structure, properties and mass of compounds synthetized in the Chemistry
Department of Silesian University, Poland courtesy of Przemyslaw Hahn.

2.2.5 Antibiotics
Kanamycin 50pg/mL (Sigma Aldrich, Dorset, UK)

Rifampicin lOOmg (Sigma Aldrich, Dorset, UK)

Ciprofloxacin lOOmg (Sigma Aldrich, Dorset, UK)
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Pyrazinamide 15mg (Sigma Aldrich, Dorset, UK)
Isoniazid 14mg (Sigma Aldrich, Dorset, UK)

2.2.6 Dried parsley water extract

2 g of dried parsley was combined with 40mL of sterile deionised water and placed in a capped
glass bottle in a shaking incubator for 48 hrs at room temperature. The solution was then filtered
using filter paper no. 4, which in turn was followed by filtration using 25 pm filter paper. The
solution was then filter-sterilized using a 0.45 pm filter and transferred to a plastic-capped tube
and stored at 4°C for further antimicrobial activity study.

2.2.7 Dried parsley methanol (20%) extract

2 g of dried parsley was combined with 16mL of sterile deionised water and 4mL of DMSO and
placed in a capped glass bottle in a shaking incubator for 48 hrs at room temperature. The
solution was then filtered using filter paper no. 4, which in turn was followed by filtration using
25 pm filter paper. The solution was then filter-sterilised using a 0.45 pm filter and transferred to
a plastic-capped tube and stored at 4°C for further antimicrobial activity study.
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2.2.8 Fresh garlic water extract

32 g of freshly chopped garlic was combined with 96mL of sterile deionised water and placed in
a capped glass bottle in a shaking incubator for 48 hrs at 42°C. The solution was then filtered
using a small-pore sieve, followed by filtration using 25 pm filter paper, which in turn was
followed by Buchner filtration using 2.5 pm filter paper. The solution was then transferred to a
plastic-capped tube (volume 50 ml) and centrifuged (Model CR 4-12, Jouan Inc., UK) for 3 min
at 3000 rpm in order to reduce the amount of debris. The supernatant was then filter-sterilised
using a 0.45 pm filter and transferred to a plastic-capped tube and stored at 4°C for further
antimicrobial activity study.

2.2.9 Dried garlic water extract

5 g of dried garlic was combined with 20mL of sterile deionised water and placed in a capped
glass bottle in a shaking incubator for 48 hrs at room temperature. The solution was then filtered
using filter paper no. 4, which in turn was followed by filtration using 25 pm filter paper. The
solution was then filter-sterilised using a 0.45 pm filter and transferred to a plastic-capped tube
and stored at 4°C for further antimicrobial activity study.

2.2.10 Dried garlic methanol (20®/o) extract

5 g of dried garlic was combined with 8mL of sterile deionised water and 32mL of DMSO and
placed in a capped glass bottle in a shaking incubator for 48 hrs at room temperature. The
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solution was then filtered using filter paper no. 4, which in turn was followed by filtration using
25 pm filter paper. The solution was then filter-sterilised using a 0.45 pm filter and transferred to
a plastic-capped tube and stored at 4°C for further antimicrobial activity study.

2.2.11 Bacterial Growth Media
2.2.11.1 Brain Heart Infusion (BHI) Agar (Sigma Aldrich, UK)
52g of BHI agar was suspended in IL of distilled water in a 2 litre glass bottle. The agar was
sterilised by m.eans of autoclaving at 121°C for 15 minutes under steam pressure at 15 psi. The
agar was then aseptically dispensed in approximate volumes of 20mL into sterile petri dishes.
Once cooled and solidified, the agar plates were stored at 4°C (upside down to prevent
condensation accumulating, and sealed in a plastic bag to prevent contamination).

2.2.11.2 Brain Heart Infusion (BHI) broth (Sigma Aldrich, UK)
37g of BHI broth powder was suspended in IL of distilled water in a 2L glass bottle. The
suspension was mixed thoroughly by boiling on a hotplate and using a magnetic stirrer. The
broth was then dispensed into lOmL volumes using a sterile pipette and pipette gun, before
sterilisation by autoclaving at 121°C for 15 minutes under steam pressure at 15 psi. BHI broths
were stored at room temperature afterwards.
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2.2.11.3 Brain Heart Infusion (BHI) Overlays (Sigma Aldrich, Dorset, UK)
In total 1 l.lg of BHI broth powder was dissolved in 300mL of distilled water along with l.lg of
agar to give a final agar concentration of 0.4%. The suspension was fully dissolved using a
hotplate and magnetic stirrer. The solution was then quickly dispensed into test-tubes in 4mL
volumes using a sterile pipette and pipette gun. Overlays were than sterilised by autoclaving at
121°C for 15 minutes under steam pressure at 15 psi. The overlays were stored at room
temperature until needed.

2.2.11.4 Middlebrook 7H9 Broth Base (Sigma Aldrich, UK)
2.35g of Middlebrook 7H9 Broth Base powder was dissolved in 450mL of distilled water. 2mL
of glycerol (Fluka, UK) was also added. Broth was sterilised by autoclaving at 121°C for 15
minutes under steam pressure at 15 psi. Broth was cooled down and then 50ml. of BBLTM
Middlebrook OADC Enrichment was added and mixed well. Broth was stored at room
temperature.

2.2.11.5 Middlebrook 7H10 Agar Base (Sigma Aldrich, UK)
I9.47g of Middlebrook 7H10 agar base powder was suspended in 900mL of distilled water in a
2L glass bottle. 5mL of glycerol (Fluka, UK) was then added. Agar was sterilised by autoclaving
at 121°C for 15 minutes under steam pressure at 15 psi and cooled down to 45°C. lOOmL of
Middlebrook OADC Enrichment (Sigma Aldrich, UK) was added and mixed well. The agar was
then aseptically dispensed in approximate volumes of 20mL into sterile petri dishes. Once cooled
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and solidified, the agar plates were stored at 4°C (upside down to prevent condensation
accumulating, and sealed in a plastic bag to prevent contamination).

2.2.11.6 Peptone Water (Sigma Aldrich, Dorset, UK)
15g of Peptone Water powder was suspended in 1L of distilled water in a 2L glass bottle and the
suspension was mixed thoroughly. Peptone water was sterilised by autoclaving at 121°C for 15
minutes under steam pressure at 15 psi and stored at room temperature afterwards.

2.2.11.7 Mycobacteriophage (MB) Buffer
60.57g of Tris powder (Sigma Aldrich, Dorset, UK, IM) and small volumes of distilled water
were added to a beaker and placed on the hot plate in order to dissolve. The pH of the solution
was adjusted to pH 8 using HCL/NaOH solutions. Iris suspension was transferred to 500mL
conical flask and topped up with distilled water to 500mL mark and mixed thoroughly. 25mL of
Tris solution (pH8 at 50mM) was added to a clean IL glass bottle and mixed with 475mL of
distilled water. 4.35g of NaCl (150mM), 0.47g of MgCb (lOmM) and 0.1 Ig of CaCb (2mM)
were added to the suspension and mixed thoroughly. MB Buffer was stored at room temperature.

2.2.12 Isolation of bacteriophages
50mL of sample (activated sludge/toilet water) was added to 5 mL of mycobacteriophage buffer.
Equal volumes of fresh BHI broth, inoculated with early log phase V/. smegmatis, were added to
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the crude environmental samples every 24h for three consecutive days and incubated at 37°C.
Following this enrichment procedure, 2 mL of supernatant was removed and placed in a
microfuge tube and centrifuged at room temperature at 2000 x g for 5 min to pellet cellular
debris. This was then filter-sterilised using a 0.2 pm filter. 100 pi of the filter-sterilised
supernatant was added to 500 pi of early log phase M smegmatis in a microfuge tube and
incubated at 37°C for 30 min. The suspension was then added to 5 mL of BHl 0.4% overlay agar
tube tempered at 45°C and poured onto the surface of a BHl agar plate. Plates were incubated at
37°C for 48h and then examined for plaques.

2.2.13 Bacteriophage plaque assay
Once stocks had been generated, serial dilution of the bacteriophage solution was performed
until a dilution of 1x10'^ was obtained. BHl overlays were completely melted in boiling water
before placing in a water bath at 48°C to maintain them in a liquid state. 500pl of M smegmatis
culture of 10* CFU/mL (from 48 hour culture) was added to one overlay a time before lOOpl of
phage dilution was added and the mixture vortexed thoroughly. The overlays were then
immediately poured aseptically over an appropriate labelled agar plate which was swirled and
allowed to solidify at room temperature. Plates were incubated overnight at 37°C in an upright
position. The plates were examined after 48h and the PFU/mL of the phage suspension was
calculated using the plates upon which between 30 and 300 isolated plaques appeared.
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2.2.14 Purification and high-titre propagation of bacteriophages
BHI plates from plaque assay were used in the purification process. A single plaque, together
with surrounding agar was removed by sterile loop from the plate and added to lOmL of BHI
broth. The tube was then vortexed thoroughly to ensure the agar was broken up and the phage
released into solution. The tube was placed on a shaking incubator at room temperature for 2
hours. The phage suspension was filter sterilized using a sterile 0.45pm membrane filter and
syringe. The sterile phage solution was used to make ten-fold serial dilutions, which were
subsequently used in new plaque assay. Once again, one plaque was chosen, and the entire
process was repeated 3 times. BHI plates from the last purification process were used in the
high- titre propagation. BHI with very high concentration of plaques (clear plates) was chosen
and 5mL of MF^ buffer was added. Plates were placed on the rotary plate at room temperature for
15 min to allow the MP buffer to extract the phage from the media. After the incubation, the
phage was pipetted into a sterile tube. The phage suspension was filter sterilised using a sterile
0.45pm membrane filter and syringe. Plaque assay was performed to determine the overall
concentration of the lysate (PFU/mL).

2.2.15 Preparation of bacteriophage cocktail
A mycobacteriophage cocktail was obtained by combining ImL of LEI, LE2, LE3, LE4, LE5,
LE6, AS S and BWC VB purified phage solutions at concentrations of 10^ PFU/mL, to achieve a
final volume of 8mL. The bacteriophage cocktail was stored at 4°C.
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2.2.16 Subculturing of Bacterial Strains
The test tube containing the bacterial culture was vortexed thoroughly to reconstitute the cell
pellet.
lOOjul of the bacterial culture solution was then transferred to an appropriately labelled test tube
containing lOmL of fresh sterile broth (BHl/MB) to give a 1% cell suspension.
Strict aseptic techniques were employed to prevent environmental contamination.
The suspension was then incubated at 37°C so that the culture was in the exponential phase of
the bacterial growth curve for use in experiments.
Once the culture was fully grown and reached the stationary phase it was stored in the fridge at
4°C.

2.2.17 Stocking of Bacterial Strains

Cultures of bacterial isolates M. smegmatis me" 155, M kansasii, M. avium intracellulare, M.
avium hominissuis, M. tuberculosis H37Ra and MAP strain KIO were grown up on BHI/MB
agar plates and removed from the incubator before stocking. 3mL of fresh BHI/MB broth was
added to the plate, and colonies scraped off using a sterile inoculating loop. Sterile pipette tips
and micropipettes were used to remove 1.5mL of the resulting thick cell suspension, and added
to 1.5mL of sterile 80% glycerol. The suspension was vortexed thoroughly, yielding high density
cell culture in 40% glycerol. ImL of the culture was placed aseptically into each of the two
screw cap vials and clearly labelled. The procedure was carried out in a biological safety cabinet
to prevent contamination of stocks.
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2.2.18 Electron microscopy
Transmission electron microscopy (TEM) was performed on bacteriophage BWC VB and AS S
from BHI broth lysate, which were amplified to achieve high titers of 10^ plaque forming units
(PFU) per mL. Each phage sample was negatively stained with 2% (w/v) uranyl acetate on
freshly prepared carbon films. A Tecnai 10 transmission electron microscope (FEI Company,
Eindhoven, The Netherlands) at an acceleration voltage of 80kV was used to analyse the
bacteriophages. Micrographs were taken with a MegaView II CCF-camera (SIS, Munster,
Germany).

2.2.219 Host range study
M smegmatis mc^ 155, M. kansasii, M. avium wtracellulare, M. avium hominissuis, M.
tuberculosis H37Rv and MAP strain KIO were used in this study. The ability of bacteriophages
BWC VB and AS S to infect and lyse bacterial hosts was determined by a spot lysis assay.
Lawns of host bacterial species were formed by plating samples of fresh cultures onto
g

Middlebrook (Sigma Aldrich, Dorset, UK) agar plates. 0.1 mL volumes of the 10 CFU/mL
bacteriophage lysates were dropped onto the agar and the plates were incubated at 37°C for 21
days for the MAP culture and 7 days for other mycobacteria strains. Infection of the
bacteriophage with the host bacterium was revealed as a zone of lawn killing at the site of virus
addition.
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2.2.20 Antimycobacterial activity of bacteriophage against M. smegmatis lux
This study used bioluminescent bacteria as a tool for assessment of antimicrobial activity of
bacteriophages. M smegmatis lux culture was propagated in the Cork Institute of Technology by
integrating two cloning vectors; the pli4xMC3 vector, which harbours the optimized /ra:ABCDE
operon for Gram-positive bacteria and the mycobacterium pMV361 cloning vector (culture
obtained from Mr Marcel de Kruijf, Biological Sciences, CIT). 1 mL of M smegmatis lux culture
(to obtain 10^ CFU/mL; from 48 hour culture) was inoculated on the BHI plates with Kanamycin
(30 pg/mL) by swabbing the entire agar surface in order to create an even bacterial lawn. A
sterile test tube was used to cut identical 15 mm diameter oval-shaped disks in the inoculated
agar plates. 5 oval-shaped disks were placed onto the surface of a sterile petri dish and covered
with a lid. A 10-fold dilution of AS S bacteriophage lysate was carried out, resulting in a range
of different concentrations between 10"^ and 10*^ PFU/mL. 10 pi of bacteriophage lysate was
transferred by pipette to the centre of the oval-shaped disk and this was carried out for all of the
lysate dilutions. Regions of interest (ROl) (light emission) were measured using the Xenogen
I VIS® Lumina. Quantification of light emission was measured by use of Living Image software,
version 3.0. 10 pi of MB buffer was used as a positive control. Petri dishes were incubated at
37°C for 48 hours. The assay was carried out in triplicate.

2.2.21 Antibacterial activity of bacteriophage on mycobacteria-contaminated hard surfaces
This experiment used artificially contaminated materials which simulated the environment of a
farm or any industrial complex. Glass microscope slides, wooden sticks, a metal key and rubber
strips were used as examples of the hard surfaces commonly found in a farm or industrial setting.

54

After sterilisation by U.V. treatment (2 minutes under U.V. Camag lamp at 250nm), the
substrates were sequentially placed in petri dishes (one item per dish), treated with 10 pi of full
fat milk to simulate a dirty surface, since farm surfaces are often covered with organic matter.
All petri dishes were placed in a biological safety cabinet for 30 min to allow complete drying of
materials. After drying, the surfaces of the matrices were contaminated by applying lOpl of M.
smegmatis lux strain (to obtain 10^ CFU/mL

from 48 hour culture), and allowed to dry for 30

minutes in the biological safety cabinet in order to allow bacterial attachment. After drying and
attachment, the mycobacteria-contaminated surfaces were treated with sterile de-ionised water as
a control, and with phage solution AS S and phage solution BWC VB at high concentrations (10
PFU/mL), all in spray form. Samples were treated with approx. 375pl of tested solution (3
sprays) a time and let dry in the biological safety cabinet for 30 min. Tested solutions were
sprayed again (3 sprays) onto the samples’ surfaces and let dry for another 30 min. This step was
repeated once more to increase the chances of phage exposure to the host cells. In order to
enumerate the surviving cells, 5 mL of peptone water (Sigma Aldrich, Dorset, UK) was added to
each petri dish and mixed gently on a rotary plate for 5 min. A 1 mL sample was taken directly
from the petri dishes and serial dilutions were performed in peptone water for each material
sample. Serial 10-fold dilutions (10 ,10

and 10 ) of the mixtures were prepared in peptone

water. Plating was performed on BHl with kanamycin (30|ig/mL) by inoculation of 10 pi sample
by streaking over the entire sterile agar surface. Survivors were enumerated after incubation at
37 °C for 48 h. All tests were performed in triplicate.
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Figure 1: The glass mieroscope slide, wooden stick, metal key and rubber strip that were used in the
experiment to demonstrate the effects of bacteriophage on hard surfaces that mimic those of various types
of agricultural materials.

2.2.22 Determination of antimicrobial activity of phage formulations against M. smegmatis
lux on Eruca saliva (Rocket)
Eruca saliva was obtained from a local grocery shop in Cork. Individual leaves were washed
thoroughly under running tap water in order to reduce the microbial load of the plant material
due to handling and transportation. This step was repeated once. The final rinse was performed
in sterile de-ionised water. Leaves were cut into smaller pieces and air dried before use. 3
samples of 0.5 g each of the rocket were placed onto a large weigh boat and inoculated with lOpl
of M smegmatis lux culture (to obtain 10^ CFU/mL; from 48 hour culture) on the outer surface
of the leaves. Samples were placed in a biological safety cabinet for 40 min to dry and to allow
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for bacterial attachment to the surface. The inoculated lettuce samples (0.5 g each) were treated
with sterile de-ionised water as a control and phage solution AS S and phage solution BWC VB
at high concentration (10* PFU/mL), all in spray form. Samples were treated with 375pl of test
solution (3 sprays a time) and let dry in the biological safety cabinet for 30 min. Test solution
was sprayed again (3 sprays) onto the leaves’ surfaces and let dry for another 30 min. This step
was repeated once more to increase the chances of phage exposure to the host cells. In order to
enumerate the surviving cells, the leaf samples were placed in a small sterile plastic bag and the
entire leaf surface was covered by 20 mL of peptone water. Each sample was agitated gently by
hand for 1 min. 1 mL sample was taken directly from the bag and serial dilutions were performed
in peptone water for each lettuce sample. Plating was performed on BHl with kanamycin
(30pg/mL) by inoculation of 10 pi sample by streaking over the entire sterile agar surface.
Survivors were enumerated after incubation at 37 °C for 48 h. Assay was repeated in triplicate.

2.2.23 Determination of antimicrobial activity of phage formulations against M. smegmatis
lux in water and cow’s milk
lOmL volumes of test solution, either milk or water, were added to sterile T-flasks. 300pl of 48
hour M smegmatis lux culture at approx. 10* CFU/mL was then added and vortexed thoroughly.
o

lOOpl volumes of phage solutions at concentrations of 10 PFU/mL (single and phage cocktail
samples) were then added. lOOpl of phage buffer was added instead of phage formulation and
used as control. T-flasks were incubated for 24h at room temperature in a shaking incubator.
Serial dilution was carried out in order to enumerate surviving cells using plate count method on
BHl agar plates. Plates were incubated 37 °C for 48 h.
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2.2.24 Antibiotics preparation
lOOmg rifampicin was weighed out and re-suspended in ImL of DMSO. In order to achieve
concentration of 2mg/mL, 40 pL of rifampicin suspension was added to 1960pL of distilled
water. I'he antibiotic was stored for up to 7 days in the dark at room temperature.
lOOmg ciprofloxacin was weighed out and re-suspended in ImL of DMSO. In order to achieve
concentration of 2mg/mL, 40 pL of ciprofloxacin suspension was added to 1960pL of distilled
water. The antibiotic was stored for up to 7 days in the dark at room temperature.
I5mg of pyrazinamide was weighed out and re-suspended in ImL of distilled water. In order to
achieve a concentration of 2mg/mL, 267pL of pyrazinamide suspension was added to 1733pL of
distilled water. The antibiotic was made up freshly for each AlamarBlue assay.
I4mg of isoniazid was weighed out and re-suspended in ImL of distilled water. In order to
achieve a concentration of 2mg/mL, 286pL of isoniazid suspension was added to 1714pL of
distilled water. The antibiotic was made up freshly for each AlamarBlue assay.

2.2.25 Microplate-based AlamarBlue assays (MABA) for screening antimycobacterial
compounds
This experiment was used to assess the antimycobacterial properties of three groups of
compounds, including antibiotics, 1 1 substances obtained from the Chemistry Department of The
University of Silesia, Poland and the plant-based compounds as outlined in the method section.
M smegmatis, M. kansasii M. intacellulare, M. hominissuis, M.tuberculosis and MAP were
grown to log phase in 50mL Middlebrook 7H9 (MB) broth. Each bacterium was centrifuged at
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3000 rpm for 20 minutes after which supernatant was removed. The bacterial pellet was washed
three times in fresh MB broth and then re-suspended in lOmL of fresh MB broth, after which the
o

bacterial culture was adjusted to a McFarland standard number 1 (3x10 CFU/mL) and then
diluted 1:20 in MB broth.

The outer wells of 96-well plates were filled with 200pL of distilled water. All other wells were
filled with lOOpL of MB broth. lOOpL of tested compound was added to the second row and
then diluted down by removing lOOpL of compound and MB broth from the second row and
placing it in the row below (third row). Another lOOpL was taken from the third row and
transferred to the fourth row and this was continued until the final concentration of tested
substance ranged between 1000 and 8pg/mL. lOOpL of Mycobacterium culture tested was added
to wells containing all diluted compounds. Negative control wells contained only MB 7H9 broth
(200pL) and positive control wells contained bacterium but no test compound.

All the 96-well plates were wrapped in parafilm in order to reduce moisture loss, and incubated
at 37°C for 7 days. When MAP was tested, the plates were incubated for 11 days. After the
required incubation time, 20 pL of AlamarBlue was added to each of the test wells and incubated
for a further 24h at 37°C. Post 24h incubation with AlamarBlue, wells were visually inspected to
determine the MIC based on the characteristic colour change from blue to pink.

Antibiotics tested in the experiment included isoniazid, rifampicin, pyrazinamide and
ciprofloxacin and were used as controls throughout.

Plant compounds tested in these experiments included fresh and dried garlic extracts and dried
parsley extract, prepared as outlined previously.
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Other substances tested included 11 compounds obtained from the Chemistry Department of the
University of Silesia, Poland.

2.2.26 Activity of plant extracts as determined by the growth curves analysis for M.
smegmatis

Antimicrobial activity of plant compounds was demonstrated using growth curves of M
smegmatis on 96-well plate.

200pL of BUI broth was placed in the first three wells of the first row and used as a blank.
Another three wells of the third row were filled with 200pL of BHl broth and 6pL of M.
smegmatis fresh culture at lO^CFU/mL. Another three wells of the fifth, sixth and seventh rows
were filled with 200fiL of BHl broth and bpL. of M. smegmatis fresh culture at 10^ CFU/mL,
followed by removal of 50pL of mixed suspension and replacement with 50pL of a compound to
be tested, fhe fifth row contained fresh garlic water extract, the sixth row contained dried garlic
water extract and the seventh row contained dried parsley extracts at their highest concentrations.

Samples were incubated in the plate reader at 37°C with shaking. A kinetic cycle of 72 hours, 30
minute intervals and at an absorbance of 600nm was used. After reading the results were
exported as a Microsoft Excel file.
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2.2.27 Determination of antimicrobial activity of garlic formulations against M. smegmatis
on lettuce
Due to difficulties in propagating MAP in the laboratory and limited protocols available, fast
growing Mycobacterium smegmatis was used as a surrogate mycobacteria. Lettuce was obtained
from the main canteen of Cork Institute of Technology. Individual leaves were washed
thoroughly under running tap water in order to reduce the microbial load of the plant material
due to handling and transportation. This step was repeated once more. The final rinse was
performed in sterile deionised water. The leaves were cut into smaller pieces and air dried before
use. Two samples of 5 g each of the lettuce were placed onto a large weighing boat and
inoculated with 0.1 ml of M smegmatis culture, (at 10^ CFU/ml; diluted from overnight culture)
using pipette PI 000, on the outer surface of the leaves. The samples were placed in a biological
safety cabinet for 60 min to dry the excess liquid on their surface and to allow for bacterial
attachment to the surface. The inoculated lettuce samples (5 g each) were treated with 20 ml of
sterile deionised water (as a control) or 20 ml of fresh garlic water extract. The leaf samples were
placed in a small sterile plastic bag and the entire leaf surface was covered by one of the
treatments. Each sample was agitated gently by hand for 5 min and then drained and air dried
under aseptic conditions. In order to enumerate the surviving cells, one 5 g sample of lettuce for
each treatment was placed in a small sterile plastic bag containing 45mL of peptone water. Each
sample was agitated gently by hand for 1 min. A 1 ml sample was taken directly from the bag
and serial dilutions were performed in peptone water for each lettuce sample. 100 pL of each
sample was added to 0.4% BHl overlay and poured over the top of BHI agar. The remaining
CPUs were enumerated after incubation at 37 °C for 24 h. The assay was repeated twice.
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2.3 Results

2.3.1 Phage Morphology

Plaques of bacteriophages AS S and BWC VB, when plated on a lawn of M smegmatis me" 155,
appeared clear, circular and had approximately 1mm diameter, when incubated for 48h at 37°C
using 0.4% BHI overlays. There was a lack of halo surrounding the plaques (Figure 2).

A

Plaque

B

Plaque

Figure 2: Plaques of A) Phage AS S and B) phage BWC VB plated on a lawn of M smegmatis. Both
types of phage appeared to have ca. 1mm diameter without halo surrounding the plaques.
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2.3.2 Electron Microscopy
Transmission electron microscopy allowed bacteriophages to be viewed and classified by their
morphotype. Electron micrographs of negatively stained phages BWC VB and AS S obtained
using the TEM showed that they had isometric heads and long non-contractile tails, thus placing
them in the Siphoviridae family, corresponding to morphotype B1 (Ackermann, 2001). Both
bacteriophages’ tails ended in a defined clearly visible knob-shaped structure with fibres
appearing to protrude out from the end.

A

B

2WJ (rainni.,
Figure 3: Electron micrographs of A) Phage AS S and B) phage BWC VB stained negatively with 2%
uranyl acetate. Both TEM images were taken using a MegaView 11 CCD-camera. Scale bars measure 200
nm.
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2.3.3 Host range of bacteriophage
Bacterial host species

BWC VB Infectivity

AS S Infectivity

M smegmatis me 155

Clear plaques and inhibition

Clear plaques and inhibition

of bacterial growth

of bacterial growth

MAP

No plaques

No plaques

M tuberculosis

Clear plaques and inhibition

Clear plaques and inhibition

of bacterial growth

of bacterial growth

M. kansasii

No plaques

No plaques

M. intracellulare

No plaques

No plaques

M. hominissuis

No plaques

No plaques

Table 4; Host range study ofBWC VB and AS S bacteriophages on different mycobacteria species

2.3.4 Infectivity of bacteriophage against M. smegmatis lux
Bioluminescence was used as a reporter to assay antimycobacterial activity of bacteriophage to
assess cell viability and cell number.
Optical imaging of bacterial growth in vitro using engineered bioluminescent M. smegmatis
pMV 36\-lux was used to assess the antimicrobial activity of bacteriophage.
The method used in the experiment was based on bioluminescent bacteria expressing a pMV

36\-lwc reporter system that emits light, which was monitored using an I VIS® Lumina
bioimaging system (Xenogen). In this system, photons are identified by specialised charge
couple device (CCD) cameras that convert photons into electrons after striking silicon wafers.
These cameras encode the intensity of incident photons into electrical charge patterns to generate
an image. One application of the IVIS® system in living organisms involves the use of a cooled
CCD camera attached to a light-tight specimen chamber, with processing and analysis of the
resulting images performed by computer software (Sadikot and Blackwell 2005).
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Miniature BHl agar disks (15mm) with Kanamycin (30mg/mL) supplementation were inoculated
with M smegmatis lux culture (10* PFU/mL) and combined with different concentrations of AS
S phage formulations and incubated for 24h at 37°C as described earlier.
Bioluminescence was measured using Living Image software Version 3.0 (Xenogen) by
exposing the bacteria disks for 30 sec. Images were displayed using a colour scale where purple
(0 photons s-lcm-2 steridian [sr]-l) represented the least intense light and red (2500 photons slcm-2 steridian [srj-l) represented the most intense light (Figure 4A and 5A).
The total counts from, a region of interest were quantified using the Living Image software
package. The data was produced for each bacteriophage dilution and control samples.
Bioluminescence of bacteria was affected by the amount of phage present in the test samples.
The expression of the bacteria decreased as the concentration of the lysate increased (Figure 4B).
fhe control sample, that did not contain any bacteriophage, showed very high expression levels
of 1.4 X 10^ (photons s-lcm-2 steridian [sr]-l), whereas the highest concentration of phage lysate
(10*^ PFU/mL) showed only 1.7 x 10^ (photons s-lcm-2 steridian [sr]-l). In other words, a single
bacteriophage formulation was able to reduce the levels of culture expression by 87.8% at its
highest concentration (Figure 4C).
Phage cocktail contained 8 individual purified phages and, when tested against M smegmatis
lux, showed stronger antimicrobial activity when compared to single phage formulation (Figure
5B). The highest concentration of phage cocktail of 10* PFU/mL resulted in 98.4% reduction of
light expression. The activity of phage cocktail concentration at 10^ PFU/mL was nearly
identical (84.2 %) to the activity of single phage formulation at 10* PFU/mL (84.3%) (Figure
5C).
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Figure 4 (A)

Positive control, no

Phage 10 PFU/ml
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Phage 10 PFU/ml

Phage 10^ PFU/ml

Figure 4 (A): Miniature BHI agar disks (15mm) with Kanamycin (30mg/mL) supplementation inoculated
with M smegmatis Lux culture (10* PFU/mL). Each picture represents levels of light expression of
bacteria culture after application of distilled water or AS S phage lysate at different concentration after
incubation at 37°C for 48h.
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Figure 4 (B)
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Figure 4 (B): Bioluminescence (photons s-lcm-2 steridian [sr]-l)

of M smegmatis lux disks after

exposure to phage (AS S) formulation at different concentrations after incubation at 37°C for 48h
measured with IVIS® Lumina. Quantification of light emission was measured by use of Living Image
software, version 3.0. Assays were performed in triplicate and bioluminescence expression presented as
the mean ± standard deviation.
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Figure 4 (C): M smegmatis lux reduction (%) after exposure to AS S phage formulation at different
concentrations. Bacteriostatic activity quantified by relationship between bacterial light production and
bacteriophage infectivity.
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Figure 5 (A)
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Figure 5 (A): Miniature BHl agar disks (15mm diameter) with Kanamycin (30mg/mL) supplementation
inoculated with M smegmatis lux culture (10* PFU/mL). Each picture represents levels of light expression
of bacteria culture after application of distilled water or phage cocktail lysate at different concentration
after incubation at 37°C for 48h.
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Figure 5 (B)
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Figure 5 (B): Bioluminescence (photons s-lcm-2 steridian [sr]-l) of M. smegtnatis lux after exposure to
phage cocktail formulation at different concentrations after incubation at 37°C for 48h measured with
I VIS® Lumina. Quantification of light emission was measured by use of Living Image software, version
3.0. Assays were performed in triplicate and bioluminescence expression presented as the mean ±
standard deviation.
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Figure 5 (C): M smegmatis lux reduction (%) after exposure to phage cocktail formulation at different
concentrations. Bacteriostatic activity quantified based on relationship between bacterial light production
and bacteriophage infectivity.
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Comparison of Mycobacteriophage activity

Figure 6
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Figure 6: Comparison of antimicrobial activity of bacteriophage formulations M. smegmatis lux reduction
(%) after exposure to phage cocktail and single phage formulation at different concentrations.
Bacteriostatic activity represented by decreased light production cause by phage exposure.

2.3.5 Phage efficacy on mycobacteria-contaniinated hard surfaces

The ability of the bacteriophage to reduce M smegmatis on artificially contaminated hard
surfaces was evaluated as described previously (Methods 2.8). Glass microscope slides, wooden
sticks, metal scalpel blades and rubber strips were inoculated with M. smegmatis pMV ?>6\-lux at
a concentration of 1 x 10^ CFU/mL and then treated for 30 min (3 times) with sterile de-ionised
water or single bacteriophage or bacteriophage cocktail formulations at 1 x iQ CFU/mL. The
“free phages” (i.e., phages unattached to M smegmatis adhering to the surface) were removed by
washing with peptone water, and the concentrations of viable M smegmatis remaining on the
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surface were determined by a standard colony counting assay. Recoveries ofM smegmatis from
de-ionised water controls were approx. 10^ CFU/mL on all the surfaces tested. Single phage
formulation significantly reduced M. smegmatis contamination on the wood surfaces by 78.33%
and phage cocktail formulation by 87.70% (Figure 7B). When tested on glass microscope slides,
single phage formulation had weaker efficacy as it reduced bacterial growth by 56.13%, however
phage cocktail treatment reduced it by 93.96% (Figure 8B). Phage formulation showed not to be
an efficient treatment when applied on rubber as the single phage reduced the cell growth by
13.70 % and phage cocktail by 35.30% (Figure 9B). When tested on metal, single phage reduced
the M smegmatis by 37.78% and phage cocktail by 61.39 % (Figure lOB). In summary, the
phage formulation was the most efficient when applied on the wood surface and the least when
tested on rubber.
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Figure 7 (A); Cell recovery of M smegmatis after treatment of single phage (p-value= 0.071137) (10*
PFU/mL) and phage cocktail (p-value= 0.051923) (10* PFU/mL) on wood. Assays were performed in
triplicate and phage titers were expressed as the mean ± standard deviation. Figure 7 (B): M smegmatis
(CFU/mL) reduction after exposure to single phage (10* PFU/mL) and phage cocktail (10* PFU/mL)
tested on wood.
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Cell recovery after spray
treatment on Glass

8A

% CFU/ml reduction after
exposure of phage on Glass

8B

6000
48100

5000

100

_ 4000

80

E
3 3000
U

2000
2000

I

1000
0

1
II
II

56.1 ■

■ Distilled water

u_

94.0

60

■ Single Phage

T3
OJ

cc

S' Phage Cocktail
290

40
20

■ Water
■ Single Phage
■ Phage Cocktai

Spray treatment
Phage exposure on Glass

Figure 8 (A): Cell recovery of M smegmatis after treatment of single phage (p-value= 0.136151) (10^
PFU/mL) and phage cocktail (p-value= 0.060059) (10* PFU/mL) on glass. Assays were performed in
triplicate and phage titers were expressed as the mean ± standard deviation. Figure 8 (B): M. smegmatis
(CFU/mL) reduction after exposure to single phage (10* PFU/mL) and phage cocktail (10* PFU/mL)
tested on glass.
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Figure 9 (A): Cell recovery of M smegmatis after treatment of single phage (p-value= 0.101765) (10*
PFU/mL) and phage cocktail (p-value= 0.029879) (10* PFU/mL) on rubber. Assays were performed in
triplicate and phage titers were expressed as the mean ± standard deviation. Figure 9 (B): M smegmatis
(CFU/mL) reduction after exposure to single phage (10* PFU/mL) and phage cocktail (10* PFU/mL)
tested on rubber.
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Figure 10 (A); Cell recovery of M sme^atis after treatment of single phage (p-value= 0.00693) (10^
PFU/mL) and phage cocktail (p-value= 0.00678) (10* PFU/mL) on metal. Assays were performed in
triplicate and phage titers were expressed as the mean ± standard deviation. Figure 10 (B): M smegmatis
(CFU/mL) reduction after exposure to single phage (10* PFU/mL) and phage cocktail (10* PFU/mL)
tested on metal.
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2.3.6 Phage efficacy on Eruca sativa (Rocket)
Prior to phage treatment, rocket samples (0.5 g) were experimentally contaminated with lOfil of
M. smegmatis lux culture (to obtain 10^ CFU/mL; from 48 hour culture) on the outer surface of
the leaves. The application of individual bacteriophage AS S resulted in 18.25% reduction of
viable cells. Application of the phage cocktail was able to reduce M. smegmatis population by
55.88 % (Figure 12B). Administration of several bacteriophages at once in a mixture form,
provided stronger activity due to its synergetic effect.
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Figure 12 (A): Cell recovery of M smegmatis after treatment of single phage (p-value=0.038I) (10*
PFU/mL) and phage cocktail (p-value=0.000623) (10* PFU/mL) on Eruca sativa. Assays were performed
in triplicate and phage titers were expressed as the mean ± standard deviation. Figure 12 (B): M.

smegmatis (CFU/mL) reduction after exposure to single phage (10* PFU/mL) and phage cocktail (10*
PFU/mL) tested on metal.

2.3.7 Effect of bacteriophage on survival of M. smegmatis in water and cow’s milk
The survival of the M smegmatis population in low fat cow’s milk and water was determined in
the presence and in the absence of the bacteriophage formulations after a period of 24 hours.
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Surviving cells were then measured and phage efficacy presented as % reduction. Tested solution
that did not contain bacteriophage was used as a control.
When tested in milk, single phage formulation had weak inhibitory effect of 29.58% where
phage cocktail demonstrated stronger activity of 59.54 % (Figure 13B). The same experimental
method was used to test phage activity in water. Once more, individual phage lysate had limited
antimicrobial effect of 29.07%, where phage cocktail formulation resulted in 63.44% inhibition
of cell population (Figure 14B). Therefore, the phages tested in this experiment were slightly
more effective when applied to water.
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Figure 13 (A): Cell recovery of M smegmalis after treatment of single phage (p-value= 0.003438) (10*
PFU/mL) and phage cocktail (p-value= 0.004673) (10* PFU/mL) in cow’s milk. Assays were performed
in triplicate and phage titers were expressed as the mean ± standard deviation. Figure 13 (B): M.
sme^matis (CFU/mL) reduction after exposure to single phage (10* PFU/mL) and phage cocktail (10*
PFU/mL) formulations tested in cow’s milk.
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Figure 14 (A): Cell recovery of M. smegmatis after treatment of single phage (p-value= 0.050177) (10*
PFU/mL) and phage cocktail (p-value= 0.02914) (10* PFU/mL) in water. Assays were performed in
triplicate and phage titers were expressed as the mean ± standard deviation. Figure 14 (B): M smegmatis
(CFU/mL) reduction after exposure to single phage (10* PFU/mL) and phage cocktail (10* PFU/mL)
formulations tested in water.
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2.3.8 MABA assay for screening antimycobacterial compounds
2.3.8.1 Antibiotic susceptibility testing
AlamarBlue reagent was used to determine the growth of different mycobacteria when exposed
to antibiotics. This micro titer plate based assay tested rifampicin, isoniazid, pyrazinamide and
ciprofloxacin against six different mycobacterial strains. Data analysis was conducted on visual
results of colour change, when blue dye was oxidized to form pink upon reduction (Ahmed,
1994). Rifampicin was found to be the most effective of all antibiotics as it inhibited growth of
all mycobacteria tested and its MICs for all strains were of <7.8125pg/mL. Ciprofloxacin also
showed wide host range as it presented with activity of <7.8125//g/mL (MIC) for M. smegmatis,

M. inlacellulare, M. hominissuis and M tuberculosis. In addition it also showed MIC of
15.625pg/ml. when tested on M. kan.sasii. Pyrazinamide exhibited a MIC equal to 250pg/mL for

M. tuberculosis and MIC of <7.8125pg/mL for MAP culture. Mycobacteria cultures were
resistant to isoniazid apart from M tuberculosis where the MIC was <7.8125pg/mL.

Antibiotic

Solubility

INH

Yes in H2O

CPX

RIF

PZA

Yes in 20%
DMSO
Yes in 20%
DMSO

M. smegmatis

M. kansasii

M. intracellulare

M. hominiss

M. tuberculosis

MAP

MIC ng/mL

MIC rig/mL

MIC ng/mL

MIC kig/mL

MIC |ig/mL

MIC pg/mL

'

-

-

$7.8125

“

<7.8125

15.625

<7.8125

<7.8125

$7.8125

-

S7.8125

$7.8125

<7.8125

<7.8125

$7.8125

$7.8125

-

-

250

$7.8125

Yes in H2O

Table 5: Antibiotic susceptibility testing using the microplate Alamar blue assay (MABA). Data
represents minimum inhibitory concentration (MIC [pg/mL]) of isoniazid (INH), pyrazinamide (PZA),
rifampicin (RIF) and ciprofloxacin (CPX) and their solubility (in triplicate) against mycobacteria isolates.
" symbol indicates lack of bacterial inhibition of antibiotic tested at the highest concentration of 1000
pg/mL. Antibiotic range is between 7.8125 and 1000 pg/mL.
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Figure 14: Result of susceptibility testing of rifampicin and pyrazinamide on M. smegmatis using
AlamarBlue assay on 96-well plate. Positive control indicates living cells and no antibiotic present,
whereas negative control contains no cells.

2.3.8.2 Screening antimycobacterial eompounds
This study assessed the antimycobacterial activity of a bank of chemical compounds using a
microplate-based AlamarBlue assay. This experiment allowed for screening for potential drugs
that can be used in the treatment or control of mycobacterial infection. The AlamarBlue
oxidation-reduction dye was used as an indicator of cellular growth and viability. Five different
mycobacterial strains were used to investigate the efficacy of the compounds. M kansasii and
MAP cultures were resistant to all tested substances. The most effective compound (AP 22)
showed activity against M intacellulare, M. hominissuis and M. tuberculosis, however only at
very high concentrations (MIC of 1000, 1000 and 500 pg/mL respectively). The most susceptible
organism was M. tuberculosis which was inhibited by six compounds but only at high
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concentrations. Three of the eleven substances tested did not dissolve in 20% DMSO solution
and therefore were not tested in the assay. The compounds tested using the MABA assay did not
show strong antimicrobial effects, therefore in their current state they hold little promise as new
drugs in the control of mycobacteria.

Compound

M. tuberculosis

MAP

MIC pg/mL

MIC pg/mL

-

-

-

-

-

1000

-

-

-

-

1000

-

-

-

-

No inhibition

-

-

-

-

1000

-

-

-

-

1000

-

-

-

-

1000

-

1000

1000

500

-

M. kansasii

M. intracellulare

M. hominissuis

pg/mL

pg/mL

-

-

-

Solubility
pg/mL

name

pH 103.6

pH 114.2

pH 58

pH 113.6

pH 138.7

pH 114.2

pH 106.3

AP 22

Yes 20%
DSMO
Yes 20%
DSMO
Yes 20%
DSMO
Yes 20%
DSMO
Yes 20%
DSMO
Yes 20%
DSMO
Yes 20%
DSMO
Yes 20%
DSMO

AP 21

No

N/A

N/A

N/A

N/A

N/A

AP 23

No

N/A

N/A

N/A

N/A

N/A

AP 27

No

N/A

N/A

N/A

N/A

N/A

Table 6; Results of the minimum inhibitory concentration (MIC [pg/mL]) of synthetic compounds
sourced from the Chemistry Department of the University of Silesia in Poland. Antimicrobial
susceptibility results by microplate Alamar blue assay (MABA) completed in triplicate against M.
kansasii, M. intracellulare, M. \\ominissuis, M. tuberculosis and MAP isolates.

" symbol indicates lack

of bacterial inhibition on synthetic compound tested at the highest concentration of 1000 pg/mL.
Compound range is between 7.8125 and 1000 pg/mL.
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2.3.8.3 Screening antimycobacterial plant derived compounds
The antimycobacterial activity of plant derived compounds was demonstrated using a
microplate-based AlamarBlue assay. This experiment allowed testing for potential plants that can
be used in the treatment or control of mycobacterial species. Six different mycobacterial strains
were used to investigate the efficacy of plant extracts.
Dried parsley was tested in two forms as a water extract and as a 20% methanol extract. Both
parsley extracts did not show any inhibitory effects against tested mycobacteria (Table 5).
Garlic was tested in three forms as a fresh garlic water extract, dried garlic water extract and as a
dried garlic 20% methanol extract. Fresh garlic formulation showed the weakest activity against
mycobacteria among all garlic extracts tested. It demonstrated activity against M smegmatis, M.
kansasii M. intacellulare and M hominissuis at a MIC of 1000 pg/mL. Methanol extract
demonstrated stronger activity and resulted in inhibition of M. smegmatis, M. kansasii M.
intacellulare and M. hominissuis at 125, 500, 1000 and 500 pg/mL respectively. The most
effective extract tested was dried garlic water formulation as it resulted in bacterial inhibition of
M. smegmatis, M. kansasii M. intacellulare and M. hominissuis at 125, 250, 1000 and 250
pg/mL accordingly. Garlic extracts did not demonstrate inhibitory effects against M tuberculosis
and MAP.
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Extract

M. smegmatis
MIC |ig/mL

M. kansasii
MIC |ig/mL

M. intracellulare

M. hominissuis

MIC |tg/mL

MIC |ig/mL

M. tuberculosis

MAP

MIC ^g/mL

MIC |tg/mL

Dried
Parsley

-

-

-

-

-

-

-

-

-

-

-

-

125

250

1000

250

-

-

125

500

1000

500

1000

1000

1000

1000

Water
Dried
Parsley
Methanol
20%

Dried Garlic
Water
Dried Garlic
Methanol

-

20%

Fresh Garlic
Water

-

-

Table 7; Distribution of the minimum inhibitory concentration (MIC [|imol/L]) of garlic and parsley
extracts. Antimicrobial susceptibility results by microplate Alamar blue assay (MABA) completed in
triplicate against M.smegmatis, M. kansasii, M. intracellulare, M. hominissuis, M. tuberculosis and MAP
isolates.

" symbol indicates lack of bacterial inhibition on plant extract tested at the highest

concentration of 1000 pg/mL. Extract range is between 7.8125 and 1000 pg/mL.
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Figure 15: Result of MABA testing of dried parsley (A) and dried garlic (B) using water and methanol
extraction methods on M smegmatis using AlamarBlue assay on 96-well plate. Positive control indicates
living cells and no plant extract present where negative control contains no cells.

2.3.9 Activity of plant extracts demonstrated on the growth curves of M. smegmatis

The antimicrobial activity of garlic and parsley extracts were demonstrated by growth curve
analysis of M smegmatis using 96-well plate. A positive control was used that did not contain
any plant extract as seen by the standard bacterial growth curve (Figure 3). M smegmatis
displayed a characteristic pattern of growth in liquid culture of BFtI broth. The initial Lag phase
took approximately 10 hours as the bacteria grew slowly as they adapted to the conditions in the
fresh medium. This was followed by a Log phase of 55 hours during which growth was
exponential, doubling every replication cycle. The Stationary phase occurred after the 55*'^ hour
when the nutrients became limited and the rate of multiplication equalled the rate of cell death.
As seen in Figure 3, the sample that contained dried parsley water extract followed the pattern of
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the positive control sample. This suggested that parsley extract did not affect the growth of the
mycobacteria. Both fresh and dried garlic water extracts showed complete inhibiting effects as
the bacteria did not pass the initial Lag phase.
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Figure 16: Growth curves of M smegmatis after exposure to Fresh Garlic water extract (pvalue=0.002487) (333 pg/mL), Dried Garlic water extract (p-value=0.002487) (333 pg/mL) and Dried
Parsley water extract (p-value=0.22738) (333 pg/mL) during incubation period of 72h at 37°C. Study
conducted in triplicate and the absorbance (at 600nm) expressed as the mean ± standard deviation.
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2.3.10 Determination of antimicrobial activity of garlic formulations against M. smegmatis
on lettuce
A microbiological analytical method of garlic formulation against mycobacteria was applied to a
food model of lettuce. This experiment allowed testing the antimicrobial activity by enumeration
of the surviving cells after treatment with garlic formulation. Prior to treatment, lettuce samples
(5 g) were experimentally spiked with -lO^CFU/ml of M. smegmatis on the outer surface of the
leaves. The colony count of viable cells was measured after the treatment of food samples with
the garlic extract in comparison to water (control) (Figure 4). The application of fresh garlic
water extract (Method 2.2.4) resulted in 34.69% reduction of viable cells; therefore the efficacy
was not insignificant in this particular experiment. The results obtained showed that garlic could
be used as a potential anti-mycobacterial agent.

Antimicrobial activity of garlic water extract against
M. smegmatis
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Figure 17: Cell recovery of M smegmatis after treatment of garlic water extract on lettuce. Assays were
performed in triplicate and CFU/mL were expressed as the mean ± standard deviation and p-value
=0.00221. M. smegmatis reduction after exposure to garlic water formulation was 34.69%.
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2.4 Discussion
The economic losses that are caused by MAP infection in affected herds represent a major
obstacle for farmers and also for the dairy industry. The consequences of paratuberculosis have a
great impact on milk production and the general health of the animal (Vidic et al., 1994). Johne’s
disease is incurable and slowly progressive and the control of MAP is very difficult due to high
levels of resistance to many antibiotics.
In order to control the population of MAP, alternative control agents must be investigated. One
of the objectives of this study was to assess the efficacy of a bacteriophage therapy-based
approach and apply it to any industrial environments and food models.
Due to difficulties in propagating MAP in the laboratory and limited protocols available, M
smegmatis was used as an alternative organism. M sme'^matis shares many similar
characteristics with MAP, however it is non-pathogenic and fast growing, taking between 24 and
48 hours to culture. This, however, does not expand the ability to develop MAP-specific
laboratory techniques and the understanding of MAP is still limited. This, then, works as a study
model that demonstrates and helps to understand the abilities of bacteriophages to control
mycobacterial populations.
The first study described in this thesis used bioluminescent bacteria as a tool for assessment of
antimicrobial activity of bacteriophages. Bioluminescence of the bacterial strain was affected by
the amount of phage present in the test samples as the expression of the bacteria decreased as the
concentration of the lysate increased (Figure 4B and 5B). The highest concentration of phage
cocktail of 10^ PFU/mL resulted in 98.4% reduction of light expression (Figure 5C). A single
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bacteriophage formulation was able to reduce the levels of culture expression by 87.8% at 10^
PFU/mL (Figure 4C).
As well as employing conventional microbiological techniques, a mycobacterial culture that can
express luciferase genes was used to evaluate mycobacterial survival. The bioluminescence of
the recombinant M smegmatis appeared to be a true reflection of the viability of that culture and,
as such, it was suitable for use in assessing the antimycobacterial activities of the bacteriophage.
The results of bioluminescence were obtained in real time. This study concluded that
bioluminescent bacteria can be an e.xceptional tool for assessment of antimicrobial activity
against some species of mycobacteria, as, clearly, individual mycobacterial species will differ in
their susceptibilities. This data also suggests that the efforts to make bioluminescent forms of
slow-growing mycobacteria might be worthwhile, since the time savings in evaluation of the
antimycobacterial activities of phages, biocides or drugs could be beneficial.
This study also investigated the use of several phages at once, in the form of a cocktail. One of
the most obvious advantages of a cocktail is a large collective host range that may obviate the
need to characterise phage sensitivities of the infecting pathogenic bacteria. Another advantage is
that two phages may collectively kill the bacterial population more rapidly or more completely
than either phage alone. This process of synergy between phages is relatively unexplored and
further studies should focus on this relationship. To the extent that single phage types may be
insufficient for resolving infections, synergy offers a potential tool for improving phage therapy.
Scientific data demonstrating the efficacy of phage treatment for reducing mycobacterial
contamination of inanimate hard surfaces is not available. The second experiment focused on
phage applications on inanimate surfaces that mimic those of various types of agricultural
materials, such as glass, wood, metal and rubber (Section 2.2.22). The wood matrix was easier to
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decontaminate than the other hard surfaces. In all instances, the degree of decontamination
appeared to correlate with the formulation used, where phage cocktail demonstrated stronger
activity when compared with single phage formulation (Figure 11). The numerically superior
reduction of M. smegmatis counts after the application of phage cocktail suggests that it may be
possible to further improve the effectiveness of phage treatment by addition of new phage lysate
to the phage cocktail. In addition, further experiments could also focus on increasing lysate
concentrations in phage formulations or by using larger volumes of lysate per unit of surface
area.
The normal lytic cycle of a bacteriophage, that is, from the phage’s attachment to the release of
progeny from the lysed host bacterium, requires between 20 and 40 minutes (Mathews, 1994).
Thus, significant reductions in mycobacteria counts were observed during the study. However,
different types of surface matrix could influence the speed and accessibility of initial adsorption
of the phage particles to the bacterial membrane and subsequent lysis of the bacteria. For
example, more porous materials such as wood could allow for better access of the phage to reach
the bacterial cell. This experiment aimed to use the bioluminescent strain in order to detect levels
of light emission after the exposure to bacteriophage on different surface materials.
Unfortunately, due to low bacteria count, the bioluminescence was not detected. In addition,
there was no linear relationship between cell numbers and light emission. When the cells were
allowed to clump together and settle at the bottom of the test tubes, bioluminescence was
detectable at lO^CFU/mL. However, when the samples were vortexed, bioluminescence was
undetectable, due to separation of the clumps of cells.
The antimycobacterial activity of bacteriophages was demonstrated in a food model of rocket
using fast growing M smegmatis. The experiment proved that the environment provides an
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important source of new antimicrobials. The application of individual bacteriophage AS S
resulted in 18.25% reduction of viable cells. Application of the phage cocktail was able to reduce
M smegmatis population by 55.88 % (Figure 12B). Administration of several bacteriophages at
once in a mixture form, demonstrated stronger activity due to its synergetic effect.
An antimycobacterial effect was also observed when the phages were tested in milk and water.
Single phage formulation reduced viable cells to 29.58% and phage cocktail to 59.54 %
compared to untreated controls (Figure 13B). Individual phage lysate reduced cell numbers to
29.07%, and phage coektail of 63.44% (Figure 14B). These results indicated that mycophages
may have a potential application as anti-mycobacterial agents in milk. In a similar study,
conducted in CIT, the antimycobaeterial effect of phages was tested in reconstituted milk. It was
found that individual phages reduced host number by up to 7-logs and, when tested as phage
cocktail, demonstrated a reduetion of 9-log. (Rndersen et al., 2012). The approach used in these
studies highlight the potential of mycophages for applications to extend the shelf life of plant and
animal products.
The use of phage therapy in clinical studies is very limited due to the difficult approval processes
of Western regulatory frameworks. Many researchers and companies instead focus on food
safety and agricultural and industrial applications of bacteriophages. A number of companies
have established products containing phages that target particular bacteria and are approved by
the EPA, USDA and FDA. ListShieldTM and LISTEXTM PI00 are sterilising agents that target
Listeria monocytogenes in ready-to-eat foods and represent some of the first examples of phage
cocktails to obtain Generally Recognized As safe (GRAS) status from the FDA (Abuladze et al.,
2008).
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The research conducted in this project focused on the postharvest strategies that used the phages
to sterilise inanimate surfaces in an agricultural setting and control bacterial populations in foods.
Further experiments should focus on the optimisation of preharvest strategies that investigate the
phage administration routes and delivery processes. The use of phages in preharvest
administration to livestock such as cattle could prevent animal illness and minimise the pathogen
carriage in the gastro-intestinal tract. As a result, this could lead to prevention of pathogen entry
to the food supply. Further research should also focus on expanding the bank of bacteriophages
that are specific to Irish MAP isolates and aim to create a successful control method.
The approach of using bacteriophages to reduce contamination in foods by bacterial pathogens
may be one of the most environmentally friendly and natural approaches for reducing the
incidence of food-borne disease. Phages may be useful for decontaminating food processing
plants and other buildings and facilities naturally or intentionally contaminated by pathogenic
bacteria. The data presented in this project provided additional support for the idea that
mycobacteria-specific phages can be useful in preventing disease caused by food-borne bacteria,
as long as they are susceptible to the phages, and this suggests that a phage-based approach may
be warranted against other virulent bacteria.
Antibiotics, disinfectants and preservatives are examples of antimicrobial agents that are
commonly used in order to control or kill microbial populations. In general, antimicrobial agents
include synthetic, semi-synthetic or natural substances whose function is to slow or inhibit
growth and reproduction, or to kill the microorganisms altogether. When bacteria are exposed to
some antimicrobial agents, various biological or molecular responses may be developed such as
antibiotic resistance. This means that the microorganisms can evolve the ability to resist the
effects of one or more antimicrobial agents that they were originally sensitive to (Silva et al.,
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2003). The presence of antimicrobial resistance has become a major threat to public health and
can have global impact on agriculture and industry (Hampton, 2013).
This increase in the general concern about the spreading of antibiotic resistance in humans and
animals has resulted in the reduction of antibiotics as treatments for diseases and as growth
promotors in livestock. At this point, it is necessary to search for new, natural and sustainable
strategies to reduce the numbers of mycobacteria entering the food chain.

Screening of plant

secondary metabolites is an excellent method of finding new biological agents that can be used
in the control of mycobacterial populations.
The antibiotic susceptibility testing was carried out in order to determine the level of activity of
some commonly used antibiotics that are used to treat mycobacterial infections and these results
were used for comparison purposes (Table 5).
One of the studies focused on screening small molecules, chemically synthesized using the
MABA assay. The AlamarBlue oxidation-reduction dye was used as an indicator of cellular
growth and viability. The blue dye, when oxidized, forms a pink colour upon reduction. Bacterial
growth therefore was determined by visual colour change (Ahmed, 1994). A number of studies
have been successfully conducted in Cork Institute of Technology using this method and a
number of new synthetic compounds have been found to be effective against some mycobacteria
species (Tengler et al., 2013). In one study, twenty-two ring-substituted 2-hydroxynaphthalene1-carboxanilides compounds were screened for antimycobacterial activity. Some compounds
demonstrated antimycobacterial activity against the tested strains comparable or higher than the
standard isoniazid (Gonec et al., 2013).
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A number of synthetic compounds were analyzed using MABA assay (Table 6). This experiment
allowed screening for potential new drugs that could be applied to further research and
development of treatments against mycobacterial diseases. This first line experiment helped to
determine if the compounds tested have the potential to become effective drugs. The results
obtained in the experiment concluded that the efficacy was not sufficient and further
investigation is necessary. Screening for new drugs can be time consuming and not always
successful. However, in some cases, negative results can be seen as a good outcome, as they
show that compounds need to be found elsewhere.
The antimycobacterial activity of plant derived compounds was also demonstrated using a
MABA assay, growth curves and in a food model. This experiment focused on the investigation
of the antimycobacterial activity of parsley and garlic using different formulations.
Three different garlic extracts were tested in this experiment; these included fresh garlic water,
dried garlic water and dried garlic 20% methanol extracts (Table 7). The least potent from all
garlic formulations was the extract that contained fresh plant particles that were dissolved in
distilled water. Dried garlic methanol extract demonstrated stronger effects and the most
effective extract tested was dried garlic which was dissolved in water. The antibacterial activity
of garlic extracts is attributed to the presence of phytochemicals such as allicin which effectively
cause disruption of cell building blocks and have the ability to stop enzyme pathways that have
been implicated in bacterial inhibition (Rabinkov et al., 1998).
Based on the results, it can be stated that dried garlic had stronger activity when compared to the
fresh plant. This suggested that dehydration of plant material can prove beneficial when testing
for potential antibacterial activity. Furthermore, the choice of appropriate solvent can also
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influence the potency of plant extracts, as demonstrated when water showed a stronger inhibitory
effect when compared to 20% methanol.
Garlic preparations tested in different studies have demonstrated a wide spectrum of
antimicrobial activity against many species of Gram-positive and Gram-negative bacteria,
fungal, viral and parasitic microorganisms (Uchida et al., 1975) (Hughes and Lawson, 1991)
(Mirelman et al., 1987) (Tsai et al., 1985). Knowledge of anti mycobacterial activity of garlic is
limited to only few studies that demonstrated effects against some TB strains (Ratnakar and
Murthy, 1996) (Jain, 1993).
Garlic extracts used in the MABA assay demonstrated inhibitory effects against M. smegmatis,
M. kansasii, M. intracellulare, and M hominissuis (Table 7). In addition, the fresh and dried
garlic water extracts also showed complete inhibiting effects, demonstrated by growth curve
analysis of M smegmatis using 96-well plate (Figure 16). These results suggest that garlic
extracts have the potential to be used as antimicrobial agents in order to control mycobacterial
levels.
Parsley contains several biologically active components that have demonstrated some
antibacterial and antifungal activity when tested in vitro (Manderfeld et al., 1997). Research on
the antimycobacterial activity of parsley is non-existant and the data collected during this study
improved

the

existing knowledge on the antimicrobial

activity of this

plant.

The

antimycobacterial activity of dried parsley was evaluated using water and methanol as solvents
(Table 7). Both extracts did not show any inhibitory activity against tested mycobacteria and
therefore do not show any potential as antimycobacterial agents, although experimentation with
other solvents and methods of extraction may improve functionality.
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Plant extracts can be used as potential biocontrols and are an obvious alternative to chemical
antimicrobials. Further phytochemical studies could include purification and characterisation of
the active ingredients found in garlic, parsley or other plant species.
The antimycobacterial activity of garlic extract was demonstrated in a food model of lettuce
using fast growing M smegmatis (Figure 17). This experiment, together with in vitro MABA
assay and growth curve analysis results suggested that garlic extracts could be selected for use as
potentially effective antimycobacterial agents in foods such as lettuce. It must be remembered
that the high concentrations of garlic extracts that are needed for microbial stability may become
organoleptically undesirable, when applied to particular foods. This experiment proved that the
plant kingdom provides an important source of new medicines that can be used in the treatment
of mycobacteria-related diseases, due to extensive chemical diversity. The approach used in
these studies can be applied to many food processing environments, including as a means of
extending the shelf life of plant and animal products. Further studies could also include attempts
to control mycobacteria by administration of samples of whole plants, or further investigation of
phytochemicals as additives to animal feeds.
Due to negative consumer perceptions regarding artificial preservatives, research is heading
towards alternatives such as bio preservation or the use of plant based products.
In summary, bacteriophages, plants and their constituents can reduce and control the growth of
food-borne pathogens including mycobacteria. These can be used as natural preservative agents,
that can provide an alternative to synthetic antimicrobial agents, as they can be widely cultivated
and are generally effective and safe for both human and animal consumption.
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